Document:

Exhibit 10.1

 

LOCK-UP AGREEMENT

 

December 18, 2020

 

Deerfield Healthcare Technology Acquisitions
Corp.

780 Third Avenue

New York, New York 10017

 

Ladies and Gentlemen:

 

This letter agreement (this “Agreement”)
relates to a Business Combination Agreement entered into as of December 18, 2020 (the “Business Combination Agreement”)
by and among Deerfield Healthcare Technology Acquisitions Corp., a Delaware corporation (“DFHT”) and the other
parties thereto. Capitalized terms used and not otherwise defined herein are defined in the Business Combination Agreement and
shall have the meanings given to such terms in the Business Combination Agreement.

 

		1.	In order to induce all parties to consummate the transactions contemplated by the Business Combination
Agreement, the undersigned hereby agrees that:

 

(a)
with respect to the Founder Shares held by the undersigned, and any shares of DFHT Class A Common Stock issuable in exchange thereof,
from the date hereof until the earliest of (1) twelve (12) months after the Closing Date, (2) the date on which the VWAP (as defined
in the Business Combination Agreement) of DFHT Class A Common Stock is equal to or greater than $12.50 (as adjusted for stock splits,
stock dividends, reorganizations, recapitalizations and the like) for any twenty (20) Trading Days within any thirty (30)-Trading
Day period commencing at least one hundred fifty (150) calendar days after the Closing Date, and (3) the date following the completion
of the transactions contemplated by the Business Combination Agreement on which DFHT completes a Change of Control Transaction
(as defined in the Business Combination Agreement);

 

(b)
with respect to shares of DFHT Class A Common Stock purchased pursuant to the Deerfield PIPE and held by the undersigned (the “Deerfield
PIPE Shares”), from the date hereof until the earliest of (1) nine (9) months after the Closing Date, (2) the date on
which the VWAP of DFHT Class A Common Stock is equal to or greater than $12.50 (as adjusted for stock splits, stock dividends,
reorganizations, recapitalizations and the like) for any twenty (20) Trading Days within any thirty (30)-Trading Day period commencing
at least one hundred fifty (150) calendar days after the Closing Date, and (3) the date following the completion of the transactions
contemplated by the Business Combination Agreement on which DFHT completes a Change of Control Transaction; and

 

(c)
with respect to the 3,360,000 shares of DFHT Class A Common Stock purchased by Deerfield Partners in the Company’s initial
public offering (the “Deerfield IPO Shares”), from the date hereof until the earliest of (1) six (6) months
after the Closing Date and (2) the date following the completion of the transactions contemplated by the Business Combination Agreement
on which DFHT completes a Change of Control Transaction; and

 

     

     

    

 

(d)
with respect to the shares of DFHT Class A Common Stock (i) received as Closing Date Equity Consideration, IMC Earnout
Consideration or CareMax Earnout Consideration pursuant to the transactions contemplated by the Business Combination
Agreement or (ii) held by any director or executive officer of DFHT immediately after the Closing (all such shares, together
with the Founder Shares, and any shares of DFHT Class A Common Stock issuable in exchange thereof, the Deerfield PIPE Shares
and the Deerfield IPO Shares, the “Lock-Up Shares”), from the date hereof until the earliest of (1) nine
(9) months after the Closing Date, (2) the date on which the VWAP of DFHT Class A Common Stock is equal to or greater than
$12.50 (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any twenty (20)
Trading Days within any thirty (30)-Trading Day period commencing at least one hundred fifty (150) calendar days after the
Closing Date, and (3) the date following the completion of the transactions contemplated by the Business Combination
Agreement on which DFHT completes a Change of Control Transaction;

 

(the
applicable period set forth in each of clauses (a), (b), (c) and (d), the “Lock-Up Period”), the undersigned
will not: (i) sell, offer to sell, contract or agree to sell, hypothecate, pledge, grant any option to purchase or otherwise dispose
of or agree to dispose of, directly or indirectly, or establish or increase a put equivalent position or liquidate or decrease
a call equivalent position within the meaning of Section 16 of the Exchange Act, with respect to any
Lockup Shares, (ii) enter into any swap or other arrangement that transfers to another, in whole or in part, any of the
economic consequences of ownership of any of the Lock-Up Shares, in cash or otherwise, or (iii) publicly announce any intention
to effect any transaction specified in clause (i) or (ii).

 

		2.	The undersigned hereby authorizes DFHT to cause its transfer agent for DFHT Common Stock to decline
to transfer, and to note stop transfer restrictions on the stock register and other records relating to, the Lock-Up Shares during
the Lock-Up Period, as applicable thereto.

 

		3.	Notwithstanding the foregoing, the undersigned may sell or otherwise transfer Lock-Up Shares during
the undersigned’s lifetime or on death (or, if the undersigned is not a natural person, during its existence):

 

		(a)	if the undersigned is not a natural person, to its direct or indirect equity holders or to any
of its other affiliates;

 

		(b)	as a bona fide gift or gifts;

 

		(c)	to the immediate family members (including spouses, significant others, lineal descendants, brothers
and sisters) of the undersigned;

 

		(d)	to a family trust, foundation or partnership established for the exclusive benefit of the undersigned,
its equity holders or any of their respective immediate family members;

 

		(e)	to a charitable foundation controlled by the undersigned, its equity holders or any of their respective
immediate family members;

 

		(f)	if the undersigned is not a natural person, to any affiliate, subsidiary, employee, officer, director,
investment fund controlled or managed by the undersigned or its affiliates, or commonly controlled or managed investment fund;
or

 

		(g)	if the undersigned is not a natural person, through distributions to limited or general partners,
members, managers, equity holders, stockholders or affiliates of the undersigned or via the admission of new equity holders, partners,
members or managers into any entity holding any of the Lock-Up Shares.

 

provided, however,
that in the case of any sale or transfer pursuant to clauses (a) through (g) above, such sale or transfer shall be
conditioned upon entry by such transferees into a written agreement, addressed to DFHT, agreeing to be bound by the transfer restrictions
and the other terms and conditions of this Agreement in the form attached as Exhibit A hereto.

 

     

     

    

 

		4.	The restrictions set forth in this Agreement shall not apply to:

 

		(a)	the establishment of a trading plan pursuant to Rule 10b5-1 under the Exchange Act for the sale
or transfer of Lock-Up Shares; provided, however, that such plan does not provide for the sale or transfer
of Lock-Up Shares during the Lock-Up Period;

 

		(b)	any shares of DFHT Common Stock purchased by the undersigned in the open market or in any public
or private capital raising transaction of DFHT (other than the Deerfield PIPE) or otherwise any shares of DFHT Common Stock (or
other securities of DFHT) other than the Lock-Up Shares; or

 

		(c)	the inclusion of any Lock-Up Shares (but not the subsequent sale or transfer of such Lock-Up Shares)
as part of any resale shelf registration statement filed pursuant to the A&R Registration Rights Agreement.

 

		5.	The undersigned hereby represents and warrants that the undersigned has full power and authority
to enter into this Agreement and that this Agreement constitutes the legal, valid and binding obligation of the undersigned, enforceable
in accordance with its terms. Upon request, the undersigned will execute any additional documents reasonably necessary in connection
with enforcement hereof.

 

		6.	This Agreement constitutes the entire agreement and understanding of the parties hereto in respect
of the subject matter hereof and supersedes all prior understandings, agreements, or representations by or among the parties hereto,
written or oral, to the extent they relate in any way to the subject matter hereof. Each of DFHTA Sponsor LLC, a Delaware limited
liability company (the “Sponsor”), the CareMax Representative and IMC Holdings, L.P. shall be an express third
party beneficiaries of this Agreement and shall have the right to enforce the terms of this Agreement directly against the undersigned
holders of Lock-Up Shares as if Sponsor, the CareMax Representative and IMC Holdings, L.P. were original parties hereto. This Agreement
may not be changed, amended, modified or waived (other than to correct a typographical error) as to any particular provision, except
by a written instrument executed by DFHT, the undersigned, the Sponsor, the CareMax Representative and IMC Holdings, L.P.

 

		7.	For the avoidance of any doubt, the parties hereto acknowledge and agree that the undersigned shall
retain all of its rights as a stockholder of DFHT during the Lock-up Period, including the right to vote, and to receive any dividends
and distributions in respect of, any DFHT Common Stock.

 

		8.	No party hereto may assign either this Agreement or any of its rights, interests, or obligations
hereunder without the prior written consent of the other party. Any purported assignment in violation of this paragraph shall be
void and ineffectual and shall not operate to transfer or assign any interest or title to the purported assignee. This Agreement
shall be binding on the undersigned and its successors and assigns.

 

		9.	This Agreement shall be governed by and construed and enforced in accordance with the laws of the
State of Delaware, without giving effect to conflicts of law principles that would result in the application of the substantive
laws of another jurisdiction. The parties hereto (i) all agree that any action, proceeding, claim or dispute arising out of, or
relating in any way to, this Agreement shall be brought and enforced in the Delaware Chancery Court, or if such court does not
have subject matter jurisdiction, in any court of the United States located in the State of Delaware, and irrevocably submits to
such jurisdiction and venue, which jurisdiction and venue shall be exclusive and (ii) waives any objection to such exclusive jurisdiction
and venue or that such courts represent an inconvenient forum.

 

		10.	Any notice, consent or request to be given in connection with any of the terms or provisions of
this Agreement shall be in writing and shall be sent by overnight mail or similar private courier service, by certified mail (return
receipt requested) or email transmission to the address or email address (as applicable) set forth below such party’s name
on the signature page hereto.

 

		11.	This Agreement may be executed and delivered in one or more counterparts (including by facsimile,
electronic mail, in .pdf or other electronic submission) and by different parties in separate counterparts, with the same effect
as if all parties hereto had signed the same document. All counterparts so executed and delivered shall be construed together and
shall constitute one and the same agreement.

 

		12.	This Agreement shall become effective on the Closing Date. This Agreement and the obligations of
each party hereunder shall automatically terminate upon the termination of the Business Combination Agreement in accordance with
its terms. Upon termination or expiration of this Agreement, no party shall have any further obligations or liabilities under this
Agreement; provided, however, that such termination or expiration shall not relieve any party from liability for any willful
breach of this Agreement occurring prior to its termination.

 

[Signature on the following page]

 

     

     

    

 

Very truly yours,

 

	DEERFIELD PARTNERS, L.P.	 
	 	 	 
	By:  	Deerfield Mgmt, L.P.	 
	 	General Partner	 
	 	 	 
	By:	J.E. Flynn Capital, LLC	 
	 	General Partner	 
	 	 	 
	By:	 /s/ David J. Clark	 
	 	Name: David J. Clark	 
	 	Title: Authorized Signatory	 

 

	Address:
	Email:

 

[Signature Page
to Lockup Agreement]

 

     

     

    

 

 

Very truly yours,

 

	DFHTA SPONSOR LLC
	 	 
	By:	 /s/ Lawrence Atinsky	 
	 	Name: Lawrence Atinsky
	 	Title: Manager

	 	 
	Address:	 
	Email:	 
	 	 

 

[Signature Page
to Lockup Agreement]

 

    

     

    

 

Very truly yours,

 

	 
	 /s/ Richard Barasch	 
	Richard Barasch
	 
	 /s/ Steven Hochberg	 
	Steven Hochberg
	 
	 /s/ Christopher Wolfe	 
	Christopher Wolfe
	 
	 /s/ Peter F. Fitzgerald	 
	Dr. Peter F. Fitzgerald
	 
	 /s/ Linda Grais	 
	Dr. Linda Grais
	 
	 /s/ David J. Shulkin	 
	Hon. Dr. David J. Shulkin

 

[Signature Page
to Lockup Agreement]

 

    

     

    

 

Very truly yours,

 

	O.M. INVESTMENT GROUP, INC.
	 	 
	By:	/s/ Carlos A. de Solo	 
	Name:	Carlos A. de Solo
	Title:	Chief Executive Officer
	 	 
	Address:	 
	Email:	 
	 	 
	C.G.D. INVESTMENT GROUP, INC.
	 	 
	By:	/s/ Alberto R. de Solo	 
	Name:	Alberto R. de Solo
	Title:	Chief Executive Officer
	 	 
	Address:	 
	Email:	 
	 	 
	JOSEPH N. DE VERA, INC.
	 	 
	By:	/s/ Joseph N. De Vera	 
	Name:	Joseph N. De Vera
	Title:	Chief Executive Officer
	 	 
	Address:	 
	Email:	 
	 	 
	NKP CAREMAX, LLC
	 	 
	By:	/s/ Nayan K. Pathak	 
	Name:	Nayan K. Pathak
	Title:	Manager
	 	 
	Address:	 
	Email:	 
	 	 
	MOUQUIN TROTTER, INC.
	 	 
	By:	/s/ Benjamin Quirk	 
	Name:	Benjamin Quirk
	Title:	President
	 	 
	Address:	 
	Email:	 
	 	 

 

[Signature Page
to Lockup Agreement]

 

    

     

    

 

Very truly yours,

 

	IMC HOLDINGS, LLC
	 	 
	By:	/s/ William C. Lamoreaux	 
	Name:	William C. Lamoreaux
	Title:	Chief Executive Officer
	 	 
	Address:	 
	Email:	 

 

[Signature Page
to Lockup Agreement]

 

    

     

    

 

Very truly yours,

 

	DEERFIELD HEALTHCARE TECHNOLOGY 

ACQUISITIONS CORP.
	 	 
	By:	/s/ Christopher Wolfe	 
	Name:	Christopher Wolfe
	Title:	Chief Financial Officer

 

[Signature Page
to Lockup Agreement]

 

    

     

    

 

EXHIBIT A 

 

JOINDER TO LOCK-UP AGREEMENT

 

The undersigned is executing and delivering
this Joinder to the Lock-up Agreement by and among Deerfield Healthcare Technology Acquisitions Corp. (the “Company”)
dated ___, 2020 and the other parties thereto (as the same may hereafter be amended, the “Lock-Up Agreement”).

 

The undersigned received Lock-Up Shares
(as defined in the Lock-Up Agreement) pursuant to a transaction set forth in Section 3 of the Lock-Up Agreement. By executing and
delivering this Joinder to the Company, the undersigned hereby agrees to become a party to, to be bound by, and to comply with
the provisions of the Lock-Up Agreement as a holder of Lock-Up Shares in the same manner as if the undersigned were an original
signatory to the Lock-Up Agreement.

 

Accordingly, the undersigned has executed
and delivered this Joinder as of the ___ day of ________, 20__. 

 

	 	 
	 	[●]
	 	 
	 	By:	      
	 	 
	 	Its:
	 	 
	 	Address
    for Notices: [●]
	 	 
	 	[●]
	 	 
	 	[●]
	 	 
	 	[●]Exhibit 10.2

 

AMENDED AND RESTATED REGISTRATION RIGHTS
AGREEMENT

 

This AMENDED AND RESTATED
REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made as of December 18, 2020, by and among (i) Deerfield
Healthcare Technology Acquisitions Corp., a Delaware corporation (“Pubco”), (ii) DFHTA Sponsor LLC, a Delaware
limited liability company (“Sponsor”), (iii) each of the Persons listed on the Schedule of Investors attached
hereto as of the date hereof, and (iv) each of the other Persons set forth from time to time on the Schedule of Investors who,
at any time, own securities of Pubco and enter into a joinder to this Agreement agreeing to be bound by the terms hereof (each
Person identified in the foregoing (ii) through (iv), an “Investor” and, collectively, the “Investors”).
Unless otherwise provided in this Agreement, capitalized terms used herein shall have the meanings set forth in Section 11
hereof.

 

WHEREAS, Pubco and
certain of the Investors (the “Original Holders”) are parties to that certain Registration Rights Agreement,
dated as of July 16, 2020 (the “Prior Agreement”);

 

WHEREAS, the Original
Holders currently hold an aggregate of 3,593,750 shares (the “Founder Shares”) of Class B ordinary common stock
of Pubco, par value $0.0001 per share, issued prior to Pubco’s initial public offering;

 

WHEREAS, the Original
Holders currently hold an aggregate of 3,588,667 warrants (the “Private Placement Warrants”) to purchase, at
an exercise price of $11.50 per share (subject to adjustment), shares of Common Stock;

 

WHEREAS, Pubco, CareMax
Medical Group, LLC, a Florida limited liability company (“CareMax”) and IMC Medical Group Holdings, LLC, a Delaware
limited liability company (“IMC” and, together with CareMax, each a “Company” and collectively,
the “Companies”) have entered into a Business Combination Agreement, dated as of December 18, 2020 (the “Business
Combination Agreement”), pursuant to which, and subject to the terms and conditions thereof, PubCo has agreed to acquire
all of the issued and outstanding equity interests of the Companies (the “Business Combination”);

 

WHEREAS, in connection
with the execution and delivery of the Business Combination Agreement, Pubco and certain of the Deerfield Investors have entered
into subscription agreements, dated as of December 18, 2020 (the “Subscription Agreements”), pursuant to which,
and subject to the terms and conditions thereof, such Deerfield Investors have agreed to purchase an aggregate of 10,000,000 shares
of Common Stock (the “PIPE Shares”); and

 

WHEREAS, the parties
to the Prior Agreement desire to amend and restate the Prior Agreement in its entirety on the terms and conditions included herein
and to include the recipients of the other Registrable Securities identified herein.

 

NOW, THEREFORE, in
consideration of the mutual covenants contained herein and other good and valuable consideration, the receipt and sufficiency of
which are hereby acknowledged, the parties to this Agreement hereby agree as follows:

 

    

     

    

 

1.                  
Resale Shelf Registration Rights.

 

(a)                Registration
Statement Covering Resale of Registrable Securities. Pubco shall use its reasonable best efforts to prepare and file or
cause to be prepared and filed with the Commission, no later than thirty (30) days following the consummation of the Business
Combination (the “Filing Deadline”), a Registration Statement for an offering to be made on a continuous
basis pursuant to Rule 415 of the Securities Act registering the resale from time to time by the Investors of all of the
Registrable Securities held by the Investors (the “Resale Shelf Registration Statement”). The Resale Shelf
Registration Statement shall be on Form S-1; provided, that Pubco shall file, within thirty (30) days of such time as Form
S-3 (“Form S-3”) is available for the Resale Shelf Registration Statement, a post-effective amendment to
the Resale Shelf Registration Statement then in effect, or otherwise file a Registration Statement on Form S-3, registering
the Registrable Securities for resale in accordance with the immediately preceding sentence on Form S-3 (provided that Pubco
shall maintain the effectiveness of the Registration Statement then in effect until such time as a Registration Statement (or
post-effective amendment) on Form S-3 covering such Registrable Securities has been declared effective by the Commission).
Pubco shall use reasonable best efforts to cause the Resale Shelf Registration Statement to be declared effective as soon as
possible after filing, but in no event later than the earlier of (i) sixty (60) days following the Filing Deadline and (ii)
three (3) Business Days after the Commission notifies Pubco that it will not review the Resale Shelf Registration Statement,
if applicable (the “Effectiveness Deadline”); provided, that, if the Registration Statement filed pursuant
to this Section 1(a) is reviewed by, and Pubco receives comments from, the Commission with respect to such Registration
Statement, the Effectiveness Deadline shall be extended to ninety (90) days following the Filing Deadline. Without limiting
the foregoing, as soon as practicable, but in no event later than three (3) Business Days, following the resolution or
clearance of all Commission comments or, if applicable, following notification by the Commission that any such Registration
Statement or any amendment thereto will not be subject to review, Pubco shall file a request for acceleration of
effectiveness of such Registration Statement (to the extent required, by declaration or ordering of effectiveness, of such
Registration Statement or amendment by the Commission) to a time and date not later than two (2) Business days after the
submission of such request. Once effective, Pubco shall use reasonable best efforts to keep the Resale Shelf Registration
Statement continuously effective and to be supplemented and amended to the extent necessary to ensure that such Registration
Statement is available or, if not available, to ensure that another Registration Statement is available, under the Securities
Act at all times for the public resale of all of the Registrable Securities until such date as all Registrable Securities
covered by the Resale Shelf Registration Statement have been disposed of in accordance with the intended method(s) of
distribution set forth in such Registration Statement (the “Effectiveness Period”). The Resale Shelf
Registration Statement shall contain a Prospectus in such form as to permit any Investor to sell such Registrable Securities
pursuant to Rule 415 under the Securities Act (or any successor or similar provision adopted by the Commission then in
effect) at any time beginning on the effective date for such Registration Statement, and Pubco shall file with the Commission
the final form of such Prospectus pursuant to Rule 424 (or successor thereto) under the Securities Act no later than the
first (1st) Business Day after the Resale Shelf Registration Statement becomes effective. The Resale Shelf
Registration Statement shall provide that the Registrable Securities may be sold pursuant to any method or combination of
methods legally available to, and requested by, the Investors. Without limiting the foregoing, subject to any comments from
the Commission, each Registration Statement filed pursuant to this Section 1 shall include a “plan of
distribution” approved by the Majority Caremax and IMC Investors and the Majority Deerfield Investors.

 

(b)                Notwithstanding
the registration obligations set forth in this Section 1, in the event that, despite Pubco’s efforts to include
all of the Registrable Securities in any Registration Statement filed pursuant to Section 1(a), the Commission informs Pubco
(the “Commission’s Notice”) that all of the Registrable Securities cannot, as a result of the
application of Rule 415 or otherwise, be registered for resale as a secondary offering on a single Registration Statement,
Pubco agrees to promptly (i) inform each of the holders thereof and use its reasonable best efforts to file amendments to the
Resale Shelf Registration Statement as required by the Commission and (ii) as soon as practicable but in no event later than
the New Registration Statement Filing Deadline, file an additional Registration Statement (a “New Registration
Statement”), on Form S-3, or if Form S-3 is not then available to Pubco for such Registration Statement, on such
other form available to register for resale the Registrable Securities as a secondary offering; provided, however, that prior
to filing such amendment or New Registration Statement, Pubco shall be obligated to use its reasonable best efforts to
advocate with the Commission for the registration of all of the Registrable Securities in accordance with any
publicly-available written or oral guidance, comments, requirements or requests of the Commission staff (the “SEC
Guidance”), including without limitation, the Manual of Publicly Available Telephone Interpretations D.29. The
Investors shall have the right to participate or have their respective legal counsel participate in any meetings or
discussions with the Commission regarding the Commission’s position and to comment or have their respective counsel
comment on any written submission made to the Commission with respect thereto. No such written submission shall be made to
the Commission to which any Investor’s counsel reasonably objects. Notwithstanding any other provision of this
Agreement, if any SEC Guidance sets forth a limitation of the number of Registrable Securities permitted to be registered on
a particular Registration Statement as a secondary offering, unless otherwise directed in writing by a holder as to its
Registrable Securities directing the inclusion of less than such holder’s pro rata amount, the number of Registrable
Securities to be registered on such Registration Statement will be reduced on a pro rata basis based on the total number of
Registrable Securities held by the Investors. In the event Pubco amends the Resale Shelf Registration Statement or files a
New Registration Statement, as the case may be, under clauses (i) or (ii) above, Pubco will use its reasonable best efforts
to file with the Commission, as promptly as allowed by Commission or SEC Guidance provided to Pubco or to registrants of
securities in general, one or more Registration Statements on Form S-3 or such other form available to register for resale
those Registrable Securities that were not registered for resale on the Resale Shelf Registration Statement, as amended, or
the New Registration Statement. If Pubco shall not be able to register for resale all of the Registrable Securities on the
Resale Shelf Registration Statement within three (3) months following the date of Pubco’s receipt of the
Commission’s Notice, then, until such Resale Shelf Registration Statement is effective, each of the Majority Caremax
Investors, the Majority IMC Investors and the Majority Deerfield Investors shall be entitled to demand registration rights
pursuant to Section 2 below as long as the demand request is a proposal to sell Registrable Securities with an aggregate
market price at the time of request of not less than $5,000,000 (the “Shelf Demand Right”).

 

    2

     

    

 

(c)               
Registrations effected pursuant to this Section 1 shall not be counted as Demand Registrations effected pursuant
to Section 2.

 

(d)               
No Investor shall be named as an “underwriter” in any Registration Statement filed pursuant to this Section
1 without the Investor’s prior written consent; provided that if the Commission requests that an Investor be identified as
a statutory underwriter in the Registration Statement, then such Investor will have the option, in its sole and absolute discretion,
to either (i) have the opportunity to withdraw from the Registration Statement upon its prompt written request to Pubco, in which
case Pubco’s obligation to register such Investor’s Registered Securities shall be deemed satisfied or (ii) be included
as such in the Registration Statement. Each Registration Statement (and each amendment or supplement thereto, and each request
for acceleration of effectiveness thereof) shall be provided to (and shall be subject to the approval, which shall not be unreasonably
withheld or delayed, of) the Investors prior to its filing with, or other submission to, the Commission; provided that, Pubco shall
not be deemed to be in breach of any Effectiveness Deadline or other deadline set forth in this Agreement if the failure of Pubco
to meet such deadline is the result of an Investor’s failure to approve such Registration Statement or amendment or supplement
thereto or request for acceleration thereof.

 

(e)                In
the event that on any Trading Day (as defined below) (the “Registration Trigger Date”) the number of
shares available under the Registration Statements filed pursuant to this Section 1 is insufficient to cover all of the
Registrable Securities (without giving effect to any limitations on the exercise or conversion of any securities exercisable
for, or convertible into, Registrable Securities and, in the case of Registrable Securities issuable upon the exercise of
warrants, assuming the exercise of such warrants for cash), Pubco shall amend such Registration Statements, or file a new
Registration Statement (on the short form available therefor, if applicable), or both, so as to cover the total number of
Registrable Securities so issued or issuable (without giving effect to any limitations on the exercise or conversion of any
securities exercisable for, or convertible into, Registrable Securities and, in the case of Registrable Securities issuable
upon the exercise of warrants, assuming the exercise of such warrants for cash) as of the Registration Trigger Date as soon
as practicable, but in any event within fifteen (15) days after the Registration Trigger Date. Pubco shall use its reasonable
best efforts to cause such amendment and/or new Registration Statement to become effective as soon as practicable following
the filing thereof, but in any event Pubco shall cause such amendment and/or new Registration Statement to become effective
within sixty (60) days of the Registration Trigger Date (or ninety (90) days if the applicable Registration Statement or
amendment is reviewed by, and comments are thereto provided from, the Commission) or as promptly as practicable in the event
Pubco is required to increase its authorized shares. “Trading Day” shall mean any day on which the Common
Stock is traded for any period on the principal securities exchange or other securities market on which the Common Stock is
then being traded.

 

    3

     

    

 

2.                  
Demand Registrations.

 

(a)               
Requests for Registration. Subject to the terms and conditions of this Agreement and of the Lock-Up Agreements, at
any time or from time to time, provided that Pubco does not then have an effective Registration Statement outstanding covering
all of the Registrable Securities, the holders of Registrable Securities may request registration under the Securities Act of all
or any portion of their Registrable Securities on Form S-1 or any similar long-form registration statement (“Long-Form
Registrations”) or, if available, on Form S-3 (including a shelf registration pursuant to Rule 415 under the Securities
Act) or any similar short-form registration statement, including an automatic shelf registration statement (as defined in Rule
405) (an “Automatic Shelf Registration Statement”), if available to Pubco (“Short-Form Registrations”),
in accordance with Section 2(b) and Section 2(c) below (such holders being referred to herein as the “Initiating
Investors” and all registrations requested by the Initiating Investors being referred to herein as “Demand Registrations”).
Each request for a Demand Registration shall specify the approximate number of Registrable Securities requested to be registered
and the intended method of distribution. Subject to Sections 10(a) and 10(b) (collectively, the “MNPI Provisions”),
within five (5) Business Days after receipt of any such request, Pubco shall give written notice of such requested registration
to all other holders of Registrable Securities and, subject to the terms and conditions set forth herein, shall include in such
registration (and in all related registrations and qualifications under state blue sky laws or in compliance with other registration
requirements and in any related underwriting) all such Registrable Securities with respect to which Pubco has received written
requests for inclusion therein within five (5) Business Days after the receipt of Pubco’s notice. Each holder of Registrable
Securities agrees that such holder shall treat as confidential the receipt of the notice of Demand Registration and shall not disclose
or use the information contained in such notice of Demand Registration without the prior written consent of Pubco until such time
as the information contained therein is or becomes available to the public generally, other than as a result of disclosure by the
holder in breach of the terms of this Agreement.

 

(b)                Long-Form
Registrations. (i) The Majority Caremax Investors, on behalf of any and all Caremax Investors, may request one (1)
Long-Form Registration in which Pubco shall pay all Registration Expenses whether or not any such Long-Form Registration has
become effective, (ii) the Majority IMC Investors, on behalf of any and all IMC Investors, may request one (1) Long-Form
Registration in which Pubco shall pay all Registration Expenses whether or not any such Long-Form Registration has become
effective and (iii) the Majority Deerfield Investors may request one (1) Long-Form Registration in which Pubco shall pay all
Registration Expenses whether or not any such Long-Form Registration has become effective; in each case, provided that, Pubco
shall not be obligated to effect, or to take any action to effect, any Long-Form Registration (x) unless the aggregate market
price of the Registrable Securities requested to be registered in such Long-Form Registration exceeds $20,000,000 (or with
respect to the Shelf Demand Right, $5,000,000) at the time of request, or (y) if Pubco has already effected a Demand
Registration (which became effective) in the preceding 45-day period; provided, further, that Pubco shall only be obligated
to effect, or take any action to effect, one (1) Long-Form Registration for each of the three groups identifed in the first
sentence of this Section 2(b). A registration shall not count as the sole permitted Long-Form Registration until it has
become effective and unless the holders of Registrable Securities are able to register and sell at least 90% of the
Registrable Securities requested to be included in such registration; provided that in any event Pubco shall pay all
Registration Expenses in connection with any registration initiated as a Long-Form Registration whether or not it has become
effective and whether or not such registration has counted as one of the permitted Long-Form Registrations hereunder.

 

    4

     

    

 

(c)               
Short-Form Registrations. In addition to the Long-Form Registration provided pursuant to Section 2(b), each
of (i) the Majority Careamax Investors, on behalf of any and all Caremax Investors, (ii) the Majority IMC Investors, on behalf
of any and all IMC Investors, and (iii) the Majority Deerfield Investors shall be entitled to request Short-Form Registrations
in which Pubco shall pay all Registration Expenses whether or not any such Short-Form Registration has become effective; provided,
however, that Pubco shall not be obligated to effect any such Short-Form Registration: (i) if the holders of Registrable Securities,
together with the holders of any other securities of Pubco entitled to inclusion in such Short-Form Registration, propose to sell
Registrable Securities with an aggregate market price at the time of request of less than $5,000,000, (ii) if Pubco has already
effected three (3) Short-Form Registrations (which became effective) for the holders of Registrable Securities requesting a Short-Form
Registration pursuant to this Section 2(c), or (iii) if Pubco has already effected a Demand Registration (which became effective)
in the preceding 90-day period. Demand Registrations shall be Short-Form Registrations whenever Pubco is permitted to use any applicable
short form registration and if the managing underwriters (if any) agree to the use of a Short-Form Registration. For so long as
Pubco is subject to the reporting requirements of the Exchange Act, Pubco shall use its reasonable best efforts to make Short-Form
Registrations available for the offer and sale of Registrable Securities. If Pubco is qualified to and, pursuant to the request
of the holders of a majority of the Registrable Securities, has filed with the Commission a Registration Statement under the Securities
Act on Form S-3 pursuant to Rule 415 (a “Shelf Registration”), then Pubco shall use its reasonable best efforts
to cause the Shelf Registration to be declared effective under the Securities Act as soon as practicable after filing, and, if
Pubco is a WKSI at the time of any such request, to cause such Shelf Registration to be an Automatic Shelf Registration Statement,
and once effective, Pubco shall cause such Shelf Registration to remain effective (including by filing a new Shelf Registration,
if necessary) for a period ending on the earlier of (i) the date on which all Registrable Securities included in such registration
have been sold or distributed pursuant to the Shelf Registration or (ii) the date as of which all of the Registrable Securities
included in such registration are able to be sold within a 90-day period in compliance with Rule 144 under the Securities Act (without
any restrictions as to volume or the manner of sale or otherwise and, in the case of Registrable Securities issuable upon the exercise
of warrants, assuming the exercise of such warrants for cash). If for any reason Pubco ceases to be a WKSI or becomes ineligible
to utilize Form S-3, Pubco shall prepare and file with the Commission a Registration Statement or Registration Statements on such
form that is available for the sale of Registrable Securities.

 

(d)                Shelf
Takedowns. At any time when the Resale Shelf Registration Statement or a Shelf Registration for the sale or distribution
by holders of Registrable Securities on a delayed or continuous basis pursuant to Rule 415, including by way of an
underwritten offering, block sale or other distribution plan (each, a “Resale Shelf Registration”), is
effective and its use has not been otherwise suspended by Pubco in accordance with the terms of Section 2(f) below,
upon a written demand (a “Takedown Demand”) by any Investor that is, in either case, a Shelf Participant
holding Registrable Securities at such time (the “Initiating Holder”), Pubco will facilitate in the manner
described in this Agreement a “takedown” of Registrable Securities off of such Resale Shelf Registration (a
“take down offering”) and Pubco shall pay all Registration Expenses in connection therewith; provided
that, subject to the MNPI Provisions, Pubco will provide (x) in connection with any non-marketed underwritten takedown
offering (other than a Block Trade), at least two (2) Business Days’ notice of such Takedown Demand to each holder of
Registrable Securities (other than the Initiating Holder) that is a Shelf Participant, (y) in connection with any Block Trade
initiated prior to the three (3) year anniversary of the consummation of the Business Combination, notice of such Takedown
Demand to each holder of Registrable Securities (other than the Initiating Holder) that is a Shelf Participant no later than
noon Eastern time on the Business Day prior to the requested Takedown Demand and (z) in connection with any marketed
underwritten takedown offering, at least five (5) Business Days’ notice of such Takedown Demand to each holder of
Registrable Securities (other than the Initiating Holder) that is a Shelf Participant. In connection with (x) any
non-marketed underwritten takedown offering initiated prior to the three (3) year anniversary of the consummation of the
Business Combination and (y) any marketed underwritten takedown offering, if any Shelf Participants entitled to receive a
notice pursuant to the preceding sentence request inclusion of their Registrable Securities (by notice to Pubco, which notice
must be received by Pubco no later than (A) in the case of a non-marketed underwritten takedown offering (other than a Block
Trade), the Business Day following the date notice is given to such participant, (B) in the case of a Block Trade, by 10:00
p.m. Eastern time on the date notice is given to such participant and (C) in the case of a marketed underwritten takedown
offering, three (3) Business Days following the date notice is given to such participant), the Initiating Holder and the
other Shelf Participants that request inclusion of their Registrable Securities shall be entitled to sell their Registrable
Securities in such offering. Each holder of Registrable Securities that is a Shelf Participant agrees that such holder shall
treat as confidential the receipt of the notice of a Takedown Demand and shall not disclose or use the information contained
in such notice without the prior written consent of Pubco until such time as the information contained therein is or becomes
available to the public generally, other than as a result of disclosure by the holder in breach of the terms of this
Agreement.

 

    5

     

    

 

(e)               
Priority on Demand Registrations and Takedown Offerings. Pubco shall not include in any Demand Registration that
is an underwritten offering any securities that are not Registrable Securities without the prior written consent of the managing
underwriters and the holders of a majority of the Registrable Securities then outstanding. If a Demand Registration or a takedown
offering is an underwritten offering and the managing underwriters advise Pubco in writing that in their opinion the number of
Registrable Securities and, if permitted hereunder, other securities requested to be included in such offering exceeds the number
of Registrable Securities and other securities, if any, which can be sold in an orderly manner in such offering within a price
range acceptable to the holders of a majority of the Registrable Securities included in such underwritten offering, Pubco shall
include in such offering, prior to the inclusion of any securities which are not Registrable Securities, the Registrable Securities
requested to be included in such registration (pro rata among the holders of such Registrable Securities on the basis of the number
of Registrable Securities owned by each such holder).

 

(f)                
Restrictions on Demand Registrations and Takedown Offerings. Any demand for the filing of a Registration Statement
or for a registered offering (including a takedown offering) hereunder will be subject to the constraints of any applicable lock-up
arrangements to which any demanding Investor is party, and any such demand must be deferred until such lock-up arrangements no
longer apply.

 

(i)                 Pubco
shall not be obligated to effect any Demand Registration within 60 days prior to Pubco’s good faith estimate of the
date of filing of a Registration Statement in respect of an underwritten public offering of Pubco’s securities and for
such a period of time after such a filing as the managing underwriters request, provided that such period shall not exceed
120 days from the date of the underwriting agreement entered into in respect of such underwritten public offering. Pubco may
postpone, for up to 60 days from the date of the request (the “Suspension Period”), the filing or the
effectiveness of a Registration Statement for a Demand Registration or suspend the use of a prospectus that is part of any
Resale Shelf Registration Statement (and therefore suspend sales of the Registrable Securities included therein pursuant to
such Resale Shelf Registration Statement) by providing written notice to the holders of Registrable Securities in accordance
with Section 2(f)(ii) if the board of directors of Pubco reasonably determines in good faith that the offer or sale of
Registrable Securities would be expected to have a detrimental effect on any proposal or plan by Pubco or any subsidiary
thereof to engage in any material acquisition or disposition of assets or stock (other than in the ordinary course of
business) or any material merger, consolidation, tender offer, recapitalization, reorganization or similar transaction or
would require Pubco to disclose any material nonpublic information which would reasonably be likely to be detrimental to
Pubco and its subsidiaries; provided that in such event, the holders of Registrable Securities initially requesting such
Demand Registration or Takedown Demand shall be entitled to withdraw such request. Pubco may delay or suspend the
effectiveness of a Registration Statement filed hereunder or takedown offering pursuant to this Section 2(f)(i) only
once in any consecutive twelve-month period; provided that, for the avoidance of doubt, Pubco may in any event delay or
suspend the effectiveness of Demand Registration or takedown offering in the case of an event described under Section
5(g) to enable it to comply with its obligations set forth in Section 5(f).

 

    6

     

    

 

(ii)              
In the case of an event that causes Pubco to suspend the use of any Resale Shelf Registration as set forth in Section
2(f)(i) or pursuant to Section 5(g) (a “Suspension Event”), Pubco shall give a notice to the holders
of Registrable Securities registered pursuant to such Shelf Registration (a “Suspension Notice”), no later than
three (3) Business Days from the date of such Suspension Event, to suspend sales of the Registrable Securities and, subject to
the MNPI Provisions, such notice shall state that such suspension shall continue only for so long as the Suspension Event or its
effect is continuing (provided that in each notice Pubco shall not disclose the basis for such suspension or any material non-public
information to any Investor unless otherwise requested in writing by such Investor). Pubco shall use commercially reasonable efforts
to make the Resale Shelf Registration Statement available for the sale by Investors of Registrable Securities as soon as practicable
following a Suspension Event. A holder of Registrable Securities shall not effect any sales of the Registrable Securities pursuant
to such Resale Shelf Registration (or such filings) at any time after it has received a Suspension Notice from Pubco and prior
to receipt of an End of Suspension Notice (as defined below); provided, for the avoidance of doubt, that the foregoing shall not
restrict or otherwise affect the consummation of any sale pursuant to a contract entered into, or order placed, by any holder prior
to the delivery the Suspension Notice. Each holder of Registrable Securities agrees that such holder shall treat as confidential
the receipt of the Suspension Notice and shall not disclose the information contained in such Suspension Notice without the prior
written consent of Pubco until such time as the information contained therein is or becomes available to the public generally,
other than as a result of disclosure by such holder in breach of the terms of this Agreement. The holders of Registrable Securities
may recommence effecting sales of the Registrable Securities pursuant to the Resale Shelf Registration (or such filings) following
further written notice to such effect (an “End of Suspension Notice”) from Pubco, which End of Suspension Notice
shall be given by Pubco to the holders of Registrable Securities and to such holders’ counsel, if any, promptly following
the conclusion of any Suspension Event.

 

(iii)            
Notwithstanding any provision herein to the contrary, if Pubco shall give a Suspension Notice with respect to any Resale
Shelf Registration pursuant to this Section 2(f), Pubco agrees that it shall extend the period of time during which such
Resale Shelf Registration shall be maintained effective pursuant to this Agreement by the number of days during the period from
the date of receipt by the holders of the Suspension Notice to and including the date of receipt by the holders of the End of Suspension
Notice and provide copies of the supplemented or amended prospectus necessary to resume sales, with respect to each Suspension
Event; provided that such period of time shall not be extended beyond the date that Common Stock covered by such Resale Shelf Registration
are no longer Registrable Securities.

 

(g)                Selection
of Underwriters. In connection with any Demand Registration, the Applicable Approving Party shall have the right to
select the investment banker(s) and manager(s) to administer the offering; provided that such selection shall be subject to
the written consent of Pubco, which consent will not be unreasonably withheld, conditioned or delayed. If any takedown
offering is an underwritten offering, the Applicable Approving Party shall have the right to select the investment banker(s)
and manager(s) to administer such takedown offering. In each case, the Applicable Approving Party shall have the right to
approve the underwriting arrangements with such investment banker(s) and manager(s) on behalf of all holders of Registrable
Securities participating in such offering. All Investors proposing to distribute their securities through underwriting shall
(together with Pubco) enter into an underwriting agreement in customary form with the underwriter or underwriters selected
for such underwriting.

 

    7

     

    

 

(h)               
Other Registration Rights. Pubco represents and warrants to each holder of Registrable Securities that the registration
rights granted in this Agreement do not conflict with any other registration rights granted by Pubco. Except as provided in this
Agreement, Pubco shall not grant to any Persons the right to request Pubco to register any equity securities of Pubco, or any securities,
options or rights convertible or exchangeable into or exercisable for such securities, without the prior written consent of the
holders of a majority of the Registrable Securities then outstanding.

 

(i)                
Revocation of Demand Notice or Takedown Notice. At any time prior to the effective date of the Registration Statement
relating to a Demand Registration or the “pricing” of any offering relating to a Takedown Demand, the holders of Registrable
Securities that requested such Demand Registration or takedown offering may revoke such request for a Demand Registration or takedown
offering on behalf of all holders of Registrable Securities participating in such Demand Registration or takedown offering without
liability to such holders of Registrable Securities, in each case by providing written notice to Pubco.

 

3.                  
Piggyback Registrations.

 

(a)               
Right to Piggyback. Whenever Pubco proposes to register under the Securities Act an offering of any of its securities
on behalf of any holders thereof (other than (i) pursuant to the Resale Shelf Registration Statement, (ii) pursuant to a Demand
Registration (which, for the avoidance of doubt, is addressed in and subject to the rights set forth in, Section 2 hereof),
(iii) pursuant to a Takedown Demand (which, for the avoidance of doubt, is addressed in and subject to the rights set forth in,
Section 2 hereof), (iv) in connection with registrations on Form S-4 or S-8 promulgated by the Commission or any successor
forms, (v) pursuant to a registration relating solely to employment benefit plans, or (vi) in connection with a registration the
primary purpose of which is to register debt securities) and the registration form to be used may be used for the registration
of Registrable Securities (a “Piggyback Registration”), Pubco shall give prompt written notice to all holders
of Registrable Securities of its intention to effect such a Piggyback Registration and, subject to the terms of Sections 3(c)
and 3(d) hereof, shall include in such Piggyback Registration (and in all related registrations or qualifications under
blue sky laws or in compliance with other registration requirements and in any related underwriting) all Registrable Securities
with respect to which Pubco has received written requests for inclusion therein within ten (10) Business Days after the delivery
of Pubco’s notice; provided that any such other holder may withdraw its request for inclusion at any time prior to executing
the underwriting agreement or, if none, prior to the applicable Registration Statement becoming effective.

 

(b)               
Piggyback Expenses. The Registration Expenses of the holders of Registrable Securities shall be paid by Pubco in
all Piggyback Registrations, whether or not any such registration became effective.

 

(c)                Priority
on Primary Registrations. If a Piggyback Registration is an underwritten primary registration on behalf of Pubco, and the
managing underwriters advise Pubco in writing that in their opinion the number of securities requested to be included in such
registration exceeds the number of securities which can be sold in such offering without adversely affecting the
marketability, proposed offering price, timing or method of distribution of the offering, Pubco shall include in such
registration (i) first, the securities Pubco proposes to sell, (ii) second, the Registrable Securities requested to be
included in such registration by the Investors which, in the opinion of such underwriters, can be sold, without any such
adverse effect (pro rata among the holders of such Registrable Securities on the basis of the number of Registrable
Securities owned by each such holder), and (iii) third, other securities requested to be included in such registration which,
in the opinion of such underwriters, can be sold, without any such adverse effect.

 

    8

     

    

 

(d)               
Priority on Secondary Registrations. If a Piggyback Registration is an underwritten secondary registration on behalf
of holders of Pubco’s securities other than holders of Registrable Securities, and the managing underwriters advise Pubco
in writing that in their opinion the number of securities requested to be included in such registration exceeds the number of securities
which can be sold in such offering without adversely affecting the marketability, proposed offering price, timing or method of
distribution of the offering, Pubco shall include in such registration (i) first, the securities requested to be included therein
by the holders initially requesting such registration, (ii) second, the Registrable Securities requested to be included in such
registration by the Investors which, in the opinion of such underwriters, can be sold, without any such adverse effect (pro rata
among the holders of such Registrable Securities on the basis of the number of Registrable Securities owned by each such holder),
and (iii) third, other securities requested to be included in such registration which, in the opinion of such underwriters, can
be sold, without any such adverse effect.

 

(e)               
Other Registrations. If Pubco has previously filed a Registration Statement with respect to Registrable Securities
pursuant to Section 2 or pursuant to this Section 3, and if such previous registration has not been withdrawn or
abandoned, then Pubco shall not be required to file or cause to be effected any other registration of any of its equity securities
or securities convertible or exchangeable into or exercisable for its equity securities under the Securities Act (except on Form
S-8 or any successor form or the Resale Shelf Registration Statement or a New Registration Statement) at the request of any holder
or holders of such Registrable Securities until a period of at least 90 days has elapsed from the effective date of such previous
registration; provided, however, that Pubco shall at all times remain obligated to file, supplement and/or amend, as applicable,
each Registration Statement required to be filed pursuant to Section 1 in accordance with Sections 1(a) and 1(b), as applicable.

 

(f)                
Right to Terminate Registration. Pubco shall have the right to terminate or withdraw any registration initiated by
it under this Section 3 whether or not any holder of Registrable Securities has elected to include securities in such registration.
The Registration Expenses of such withdrawn registration shall be borne by Pubco in accordance with Section 7.

 

4.                  
Agreements of Certain Holders.

 

(a)                If
required by the managing underwriter(s), in connection with any underwritten Public Offering on or after the date hereof, any
Investor that beneficially owns 1% or more of the outstanding Common Stock on the date of such underwritten Public Offering
shall enter into lock-up agreements with the managing underwriter(s) of such underwritten Public Offering in such form as
agreed to by such managing underwriter(s). In no event shall any Investor holding Registrable Securities that is not a
director or executive officer of Pubco on the date of such underwritten Public Offering be required to enter into any such
lock-up agreement (i) that contains less favorable terms than the terms offered to any other Investor, or (ii) unless such
Investor has requested its Registrable Securities be included in such underwritten registration, after the first anniversary
of the Closing Date (as defined in the Business Combination Agreement) if it owns less than 5% of the outstanding Common
Stock on the date of such underwritten Public Offering. In addition, (i) in no event shall any Investor that is not a
director or executive officer of Pubco on the date of such underwritten Public Offering be required to enter into lockup
agreements pursuant to this Section 4(a) on more than two (2) occasions (unless such Investor is including its
Registrable Securities in an underwritten registration and such lockup is requested by the managing underwriter(s) in
connection therewith), (ii) any lock-up agreement into which any Investor enters into pursuant to this Section 4(a)
shall be for a period of not more than sixty (60) days, (iii) the obligations of the Investors to enter into lockup
agreements pursuant to this Section 4(a) shall terminate on the second anniversary of the Closing Date, (iv) no Investor
shall be required to enter into a lock-up agreement pursuant to this Section 4(a) within six (6) months following the
expiration of a previous lock-up agreement entered into by such Investor pursuant to this Section 4(a), (v) no
Investor shall be required to be subject to a lockup agreement pursuant to this Section 4(a) during the sixty (60) day
period commencing immediately following the date the Lock-Up Period (as defined in the Lock-Up Agreement) with respect to the
Common Stock issued to the Deerfield Investors in Pubco’s initial public offering terminates, and (vi) except with
respect to an offering made pursuant to a Shelf Demand Right, no Investor shall be required to be subject to a lockup
agreement pursuant to this Section 4(a) during the sixty (60) day period commencing immediately following the date the
Lock-Up Period with respect to the Common Stock issued to the IMC Investors and the Caremax Investors terminates.

 

    9

     

    

 

(b)               
The holders of Registrable Securities shall use commercially reasonable efforts to provide such information as may reasonably
be requested by Pubco, or the managing underwriter, if any, in connection with the preparation of any Registration Statement in
which the Registrable Securities of such holder are to be included, including amendments and supplements thereto, in order to effect
the Registration Statement, including amendments and supplements thereto, in order to effect the Registration of any Registrable
Securities under the Securities Act pursuant to Section 3. Notwithstanding anything else in this Agreement, Pubco shall
not be obligated to include such holder’s Registrable Securities to the extent Pubco has not received such information, and
received any other reasonably requested selling stockholder questionnaires, on or prior to the later of (i) the fifth (5th)
Business Day following the date on which such information is requested from such holder and (ii) the second (2nd) Business
Day prior to the first anticipated filing date of a Registration Statement pursuant to this Agreement.

 

5.                  
Registration Procedures. In connection with the Registration to be effected pursuant to the Resale Shelf Registration
Statement, and whenever the holders of Registrable Securities have requested that any Registrable Securities be registered pursuant
to this Agreement or have initiated a takedown offering, Pubco shall use its reasonable best efforts to effect the registration
and the sale of such Registrable Securities in accordance with the intended method of disposition thereof, and pursuant thereto
Pubco shall as expeditiously as reasonably possible:

 

(a)               
prepare in accordance with the Securities Act and all applicable rules and regulations promulgated thereunder and file with
the Commission a Registration Statement, and all amendments and supplements thereto and related prospectuses as may be necessary
to comply with applicable securities laws, with respect to such Registrable Securities and use its reasonable best efforts to cause
such Registration Statement to become effective (provided that at least two (2) Business Days before filing a Registration Statement
or prospectus or any amendments or supplements thereto, Pubco shall furnish to counsel selected by the Applicable Approving Party
copies of all such documents proposed to be filed, which documents shall be subject to the review and comment of such counsel,
and no such document shall be filed with the Commission to which any Investor or its counsel reasonably objects);

 

(b)               
notify each holder of Registrable Securities of (A) the issuance by the Commission of any stop order suspending the effectiveness
of any Registration Statement or the initiation of any proceedings for that purpose, (B) the receipt by Pubco or its counsel of
any notification with respect to the suspension of the qualification of the Registrable Securities for sale in any jurisdiction
or the initiation or threatening of any proceeding for such purpose, and (C) the effectiveness of each Registration Statement filed
hereunder;

 

(c)                prepare
and file with the Commission such amendments and supplements to such Registration Statement and the prospectus used in
connection therewith as may be necessary to keep such Registration Statement and the prospectus used in connection therewith
current, effective and available for the resale of all of the Registrable Securities required to be covered thereby for a
period ending when all of the securities covered by such Registration Statement have been disposed of in accordance with the
intended methods of distribution by the sellers thereof set forth in such Registration Statement (but not in any event before
the expiration of any longer period required under the Securities Act or, if such Registration Statement relates to an
underwritten Public Offering, such longer period as in the opinion of counsel for the underwriters a prospectus is required
by law to be delivered in connection with sale of Registrable Securities by an underwriter or dealer) and comply with the
provisions of the Securities Act with respect to the disposition of all securities covered by such Registration Statement
during such period in accordance with the intended methods of disposition by the sellers thereof set forth in such
Registration Statement;

 

    10

     

    

 

(d)               
furnish to each seller of Registrable Securities thereunder such number of copies of such Registration Statement, each amendment
and supplement thereto, the prospectus included in such Registration Statement (including each preliminary prospectus), each Free-Writing
Prospectus and such other documents as such seller may reasonably request in order to facilitate the disposition of the Registrable
Securities owned by such seller;

 

(e)               
during any period in which a prospectus is required to be delivered under the Securities Act, promptly file all documents
required to be filed with the Commission, including pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Securities Act;

 

(f)                
use its reasonable best efforts to register or qualify such Registrable Securities under such other securities or blue sky
laws of such jurisdictions as the lead underwriter or the Applicable Approving Party reasonably requests and do any and all other
acts and things which may be reasonably necessary or advisable to enable such seller to consummate the disposition in such jurisdictions
of the Registrable Securities owned by such seller (provided that Pubco shall not be required to (i) qualify generally to do business
in any jurisdiction where it would not otherwise be required to qualify but for this Section 5(f), (ii) consent to general
service of process in any such jurisdiction or (iii) subject itself to taxation in any such jurisdiction);

 

(g)               
promptly notify in writing each seller of such Registrable Securities (i) after it receives notice thereof, of the date
and time when such Registration Statement and each post-effective amendment thereto has become effective or a prospectus or supplement
to any prospectus relating to a Registration Statement has been filed and when any registration or qualification has become effective
under a state securities or blue sky law or any exemption thereunder has been obtained, (ii) subject to the MNPI Provisions after
receipt thereof, of any request by the Commission for the amendment or supplementing of such Registration Statement or prospectus
or for additional information, and (iii) at any time when a prospectus relating thereto is required to be delivered under the Securities
Act, of the happening of any event as a result of which the prospectus included in such Registration Statement contains an untrue
statement of a material fact or omits any fact necessary to make the statements therein not misleading, and, at the request of
any such seller, Pubco promptly shall prepare, file with the Commission and furnish to each such seller a reasonable number of
copies of a supplement or amendment to such prospectus so that, as thereafter delivered to the purchasers of such Registrable Securities,
such prospectus shall not contain an untrue statement of a material fact or omit to state any fact necessary to make the statements
therein not misleading;

 

(h)               
cause all such Registrable Securities to be listed on each securities exchange on which similar securities issued by Pubco
are then listed and, if similar securities are not so listed, to be listed on a securities exchange and, without limiting the generality
of the foregoing, to arrange for at least two market makers to register as such with respect to such Registrable Securities with
FINRA;

 

(i)                
if applicable, promptly effect a filing with FINRA pursuant to FINRA Rule 5110 (or successor thereto) with respect to the
public offering contemplated by resales of securities under the Resale Shelf Registration Statement (an “Issuer Filing”),
pay the filing fee required by such Issuer Filing and use its reasonable best efforts to pursue the Issuer Filing until FINRA issues
a letter confirming that it does not object to the terms of the offering contemplated by the Resale Shelf Registration Statement.

 

    11

     

    

 

 

(j)                
 provide a transfer agent and registrar for all such Registrable Securities not later than the effective date of such Registration
Statement;

 

(k)               
enter into and perform such customary agreements (including underwriting agreements in customary form) and take all such
other actions as the Applicable Approving Party or the underwriters, if any, reasonably request in order to expedite or facilitate
the disposition of such Registrable Securities (including, without limitation, if the Registration involves the Registration of
Registrable Securities involving gross proceeds in excess of $25,000,000, participating in such number of “road shows”,
investor presentations and marketing events as the underwriters managing such offering may reasonably request);

 

(l)                
make available for inspection by a representative of the Investors, other than the Deerfield Investors (such representative
to be selected by the Majority Caremax and IMC Investors), a representative of the Deerfield Investors, any underwriter participating
in any disposition pursuant to such Registration Statement and any attorney, accountant or other agent retained by any such representative
or underwriter, all financial and other records, pertinent corporate and business documents and properties of Pubco as shall be
reasonably requested to enable them to exercise their due diligence responsibility, and cause Pubco’s officers, managers,
directors, employees, agents, representatives and independent accountants to supply all information reasonably requested by any
such representative, underwriter, attorney, accountant or agent in connection with such Registration Statement; provided, however,
that any such representative or underwriter enters into a confidentiality agreement, in form and substance reasonably satisfactory
to Pubco, prior to the release or disclosure of any such information;

 

(m)             
take all reasonable actions to ensure that any Free-Writing Prospectus utilized in connection with any Demand Registration
(including any Shelf Registration) or Piggyback Registration hereunder complies in all material respects with the Securities Act,
is filed in accordance with the Securities Act to the extent required thereby, is retained in accordance with the Securities Act
to the extent required thereby and, when taken together with the related prospectus, shall not contain any untrue statement of
a material fact or omit to state a material fact necessary to make the statements therein, in light of the circumstances under
which they were made, not misleading;

 

(n)               
otherwise use its reasonable best efforts to comply with all applicable rules and regulations of the Commission;

 

(o)               
permit any holder of Registrable Securities who, in its good faith judgment (based on the advice of counsel), could reasonably
be expected to be deemed to be an underwriter or a controlling Person of Pubco to participate in the preparation of such registration
or comparable statement and to require the insertion therein of material furnished to Pubco in writing, which in the reasonable
judgment of such holder and its counsel should be included;

 

(p)               
in the event of the issuance of any stop order suspending the effectiveness of a Registration Statement, or of any order
suspending or preventing the use of any related prospectus or suspending the qualification of any Common Stock included in such
Registration Statement for sale in any jurisdiction, use its reasonable best efforts promptly to obtain the withdrawal of such
order;

 

(q)               
use its reasonable best efforts to cause such Registrable Securities covered by such Registration Statement to be registered
with or approved by such other governmental agencies or authorities as may be necessary to enable the sellers thereof to consummate
the disposition of such Registrable Securities;

 

(r)                 cooperate
with the holders of Registrable Securities covered by the Registration Statement and the managing underwriter or agent, if
any, to facilitate the timely preparation and delivery of certificates (not bearing any restrictive legends) representing
securities to be sold under the Registration Statement and enable such securities to be in such denominations and registered
in such names as the managing underwriter, or agent, if any, or such holders may request;

 

    12

     

    

 

(s)                
cooperate with each holder of Registrable Securities covered by the Registration Statement and each underwriter or agent
participating in the disposition of such Registrable Securities and their respective counsel in connection with any filings required
to be made with FINRA;

 

(t)                
if such registration includes an underwritten public offering, use its reasonable best efforts to obtain a cold comfort
letter from Pubco’s independent public accountants and addressed to the underwriters, in customary form and covering such
matters of the type customarily covered by cold comfort letters as the underwriters in such registration reasonably request;

 

(u)               
provide a legal opinion of Pubco’s outside counsel, dated the effective date of such Registration Statement (and,
if such registration includes an underwritten Public Offering, dated the date of the closing under the underwriting agreement),
with respect to the Registration Statement, each amendment and supplement thereto, the prospectus included therein (including the
preliminary prospectus) and such other documents relating thereto in customary form and covering such matters of the type customarily
covered by legal opinions of such nature, which opinion shall be addressed to the underwriters;

 

(v)               
if Pubco files an Automatic Shelf Registration Statement covering any Registrable Securities, use its reasonable best efforts
to remain a WKSI (and not become an ineligible issuer (as defined in Rule 405)) during the period during which such Automatic Shelf
Registration Statement is required to remain effective;

 

(w)             
if Pubco does not pay the filing fee covering the Registrable Securities at the time an Automatic Shelf Registration Statement
is filed, pay such fee at such time or times as the Registrable Securities are to be sold;

 

(x)               
subject to the terms of Section 2(c) and Section 2(d), if an Automatic Shelf Registration Statement has been
outstanding for at least three (3) years, at the end of the third year, refile a new Automatic Shelf Registration Statement covering
the Registrable Securities, and, if at any time when Pubco is required to re-evaluate its WKSI status Pubco determines that it
is not a WKSI, use its reasonable best efforts to refile the Registration Statement on Form S-3 and keep such Registration Statement
effective (including by filing a new Resale Shelf Registration or Shelf Registration, if necessary) during the period throughout
which such Registration Statement is required to be kept effective;

 

(y)               
cooperate with each Investor that holds Registrable Securities being offered and the managing underwriter or underwriters
with respect to an applicable Registration Statement, if any, to facilitate the timely (i) preparation and delivery of certificates
(not bearing any restrictive legends) representing Registrable Securities to be offered pursuant to such Registration Statement,
and enable such certificates to be registered in such names and in such denominations or amounts, as the case may be, or (ii) crediting
of the Registrable Securities to be offered pursuant to a Registration Statement to the applicable account (or accounts) with The
Depository Trust Company (“DTC”) through its Deposit/Withdrawal At Custodian (“DWAC”) system, in any such
case as such Investor or the managing underwriter or underwriters, if any, may reasonably request; and

 

(z)                for
so long as this Agreement remains effective, (a) cause the Common Stock to be eligible for clearing through DTC, through its
DWAC system; (b) be eligible and participating in the Direct Registration System (DRS) of DTC with respect to the Common
Stock; (c) ensure that the transfer agent for the Common Stock is a participant in, and that the Common Stock is eligible for
transfer pursuant to, DTC’s Fast Automated Securities Transfer Program (or successor thereto); and (d) use its
reasonable best efforts to cause the Common Stock to not at any time be subject to any DTC “chill,”
“freeze” or similar restriction with respect to any DTC services, including the clearing of shares of Common
Stock through DTC, and, in the event the Common Stock becomes subject to any DTC “chill,” “freeze” or
similar restriction with respect to any DTC services, use its reasonable best efforts to cause any such “chill,”
“freeze” or similar restriction to be removed at the earliest possible time.

 

    13

     

    

 

6.                  
Termination of Rights. Notwithstanding anything contained herein to the contrary, the right of any Investor to include
Registrable Securities in any Demand Registration or any Piggyback Registration shall terminate on such date that (i) such Investor
(together with its affiliates) beneficially owns less than 1% of the outstanding Common Stock, (ii) has has held the securities
for one year and (iii) may sell all of the Registrable Securities owned by such Investor pursuant to Rule 144 of the Securities
Act without any restrictions as to volume or the manner of sale or otherwise; provided, however, that with respect to any Investor
whose rights have terminated pursuant to this Section 6, if following such a termination, such Investor loses the ability
to sell all of its Registrable Securities pursuant to Rule 144 of the Securities Act without any restrictions as to volume or the
manner of sale or otherwise due to a change in interpretive guidance by the Commission or otherwise, then such Investor’s
right to include Registrable Securities in any Demand Registration or any Piggyback Registration shall be reinstated until such
time as the Investor is once again able to sell all of its Registrable Securities pursuant to Rule 144 of the Securities Act without
any restrictions as to volume or the manner of sale or otherwise.

 

7.                  
Registration Expenses.

 

(a)               
All expenses incident to Pubco’s performance of or compliance with this Agreement, including, without limitation,
all registration, qualification and filing fees, listing fees, fees and expenses of compliance with securities or blue sky laws,
stock exchange rules and filings, printing expenses, messenger and delivery expenses, fees and disbursements of custodians, and
fees and disbursements of counsel for Pubco and all independent certified public accountants, underwriters (excluding underwriting
discounts and commissions) and other Persons retained by Pubco (all such expenses being herein called “Registration Expenses”),
shall be borne by Pubco as provided in this Agreement and, for the avoidance of doubt, Pubco also shall pay all of its internal
expenses (including, without limitation, all salaries and expenses of its officers and employees performing legal or accounting
duties), the expense of any annual audit or quarterly review, the expense of any liability insurance and the expenses and fees
for listing the securities to be registered on each securities exchange on which similar securities issued by Pubco are then listed.
Each Person that sells securities hereunder shall bear and pay all underwriting discounts and commissions, underwriter marketing
costs, brokerage fees and transfer taxes applicable to the securities sold for such Person’s account and all reasonable fees
and expenses of any legal counsel representing any such Person.

 

(b)               
Pubco shall reimburse the holders of Registrable Securities included in such registration for the reasonable fees and disbursements
of one counsel chosen by the Applicable Approving Party in connection with any underwritten Demand Registration.

 

    14

     

    

 

8.                  
Indemnification.

 

(a)                Pubco
agrees to (i) indemnify, defend and hold harmless, to the fullest extent permitted by law, each Investor, each Person who
controls such Investor (within the meaning of the Securities Act or the Exchange Act) each Investor’s and control
Person’s respective officers, directors, members, partners, managers, agents, affiliates and employees from and against
all losses, claims, actions, damages, liabilities and expenses (“Losses”) caused by any untrue or alleged
untrue statement of material fact contained in any Registration Statement, prospectus, preliminary prospectus, free writing
prospectus or any amendment thereof or supplement thereto or any omission or alleged omission of a material fact required to
be stated therein or necessary to make the statements therein not misleading (in the case of a prospectus, in light of the
circumstances under which the statements therein were made), and (ii) pay to each Investor and their respective officers,
directors, members, partners, managers, agents, affiliates and employees and each Person who controls such Investor (within
the meaning of the Securities Act or the Exchange Act), as incurred, any legal and any other expenses reasonably incurred in
connection with investigating, preparing or defending any such claim, loss, damage, liability or action, except in each case
of (i) or (ii) insofar as the same are caused by or contained in any information furnished in writing to Pubco or any
managing underwriter by or on behalf of such Investor expressly for use therein; provided, however, that the indemnity
agreement contained in this Section 8 shall not apply to amounts paid in settlement of any such claim, loss, damage,
liability or action if such settlement is effected without the consent of Pubco (which consent shall not be unreasonably
withheld, conditioned or delayed), nor shall Pubco be liable in any such case for any such claim, loss, damage, liability or
action to the extent that it arises out of or is based upon an untrue or alleged untrue statement of any material fact
contained in the Registration Statement, prospectus, preliminary prospectus, free writing prospectus or any amendment thereof
or supplement thereto or omission or alleged omission to state therein a material fact required to be stated therein or
necessary to make the statements therein not misleading, in each case to the extent that such untrue statement or alleged
untrue statement or omission or alleged omission was made in the Registration Statement, prospectus, preliminary prospectus,
free writing prospectus or any amendment thereof or supplement thereto, in reliance upon and in conformity with written
information furnished by or on behalf of such Investor expressly for use in connection with such Registration Statement or to
the extent that such Loss results from an Investor’s initiation of a transaction pursuant to a Registration Statement
during a Suspension Event noticed to such Investor by Pubco in accordance with Section 2(f)(ii) hereof. In connection with an
underwritten offering, Pubco shall indemnify any underwriters or deemed underwriters, their officers and directors and each
Person who controls such underwriters (within the meaning of the Securities Act or the Exchange Act) to the same extent as
provided above with respect to the indemnification of the holders of Registrable Securities.

 

(b)               
In connection with any Registration Statement in which a holder of Registrable Securities is participating, each such holder
shall furnish to Pubco in writing such information relating to such holder as Pubco reasonably requests for use in connection with
any such Registration Statement or prospectus and, to the extent permitted by law, shall indemnify Pubco, its officers, directors,
employees, agents and representatives and each Person who controls Pubco (within the meaning of the Securities Act) against any
losses, claims, damages, liabilities and expenses resulting from any untrue or alleged untrue statement of material fact contained
in the Registration Statement, prospectus or preliminary prospectus or any amendment thereof or supplement thereto or any omission
or alleged omission of a material fact required to be stated therein or necessary to make the statements therein not misleading,
but only to the extent that such untrue or alleged untrue statement or omission is contained in any information so furnished in
writing by or on behalf of such holder or to the extent that such Loss results from an Investor’s initiation of a transaction
pursuant to a Registration Statement during a Suspension Event noticed to such Investor by Pubco in accordance with Section 2(f)(ii)
hereof; provided that the obligation to indemnify shall be individual, not joint and several, for each holder and shall be limited
to the net amount of proceeds actually received by such holder from the sale of Registrable Securities pursuant to such Registration
Statement.

 

(c)                Any
Person entitled to indemnification hereunder shall (i) give prompt written notice to the indemnifying party of any claim with
respect to which it seeks indemnification (provided that the failure to give prompt notice shall not impair any
Person’s right to indemnification hereunder to the extent such failure has not materially prejudiced the indemnifying
party in defending such claim) and (ii) unless in such indemnified party’s reasonable judgment a conflict of interest
between such indemnified and indemnifying parties may exist with respect to such claim, permit such indemnifying party to
assume the defense of such claim with counsel reasonably satisfactory to the indemnified party. If such defense is assumed,
the indemnifying party shall not be subject to any liability for any settlement made by the indemnified party without its
consent (but such consent shall not be unreasonably withheld, conditioned or delayed). An indemnifying party who is not
entitled to, or elects not to, assume the defense of a claim shall not be obligated to pay the fees and expenses of more than
one counsel (as well as one local counsel for each applicable jurisdiction) for all parties indemnified by such indemnifying
party with respect to such claim, unless in the reasonable judgment of any indemnified party a conflict of interest may exist
between such indemnified party and any other of such indemnified parties with respect to such claim. In such instance, the
conflicted indemnified parties shall have a right to retain one separate counsel, chosen by the holders of a majority of the
Registrable Securities included in the registration, at the expense of the indemnifying party. Notwithstanding anything to
the contrary contained herein, Pubco shall not, without the prior written consent of the Person entitled to indemnification,
consent to entry of any judgment or enter into any settlement or other compromise with respect to any claim in respect of
which indemnification or contribution may be or has been sought hereunder (whether or not any such indemnified Person is an
actual or potential party to such action or claim) which does not include as an unconditional term thereof the giving by the
claimant or plaintiff to the indemnified Persons of a full release from all liability with respect to such claim or which
includes any admission as to fault or culpability or failure to act on the part of any indemnified Person.

 

    15

     

    

 

(d)               
Each party hereto agrees that, if for any reason the indemnification provisions contemplated by Sections 8(a) or
8(b) are unavailable to or insufficient to hold harmless an indemnified party in respect of any losses, claims, damages,
liabilities or expenses (or actions in respect thereof) referred to therein, then each indemnifying party, in lieu of indemnifying
such indemnified party, shall contribute to the amount paid or payable by such indemnified party as a result of such losses, claims,
damages, liabilities or expenses (or actions in respect thereof) in such proportion as is appropriate to reflect the relative fault
of the indemnifying party and the indemnified party in connection with the actions which resulted in such losses, claims, damages,
liabilities or expenses, as well as any other relevant equitable considerations. The relative fault of such indemnifying party
and indemnified party shall be determined by reference to, among other things, whether any action in question, including any untrue
or alleged untrue statement of a material fact or omission or alleged omission to state a material fact, relates to information
supplied by or on behalf of such indemnifying party or indemnified party, and the parties’ relative intent, knowledge, access
to information and opportunity to correct or prevent such statement or omission. The parties hereto agree that it would not be
just or equitable if contribution pursuant to this Section 8(d) were determined by pro rata allocation (even if the holders
or any underwriters or all of them were treated as one entity for such purpose) or by any other method of allocation which does
not take account of the equitable considerations referred to in this Section 8(d). The amount paid or payable by an indemnified
party as a result of the losses, claims, damages, liabilities or expenses (or actions in respect thereof) referred to above shall
be deemed to include any legal or other fees or expenses reasonably incurred by such indemnified party in connection with investigating
or, except as provided in Section 8(c), defending any such action or claim. No Person guilty of fraudulent misrepresentation
(within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any Person who was not guilty
of such fraudulent misrepresentation. The sellers’ obligations in this Section 8(d) to contribute shall be several
in proportion to the amount of securities registered by them and not joint and shall be limited to an amount equal to the net proceeds
actually received by such seller from the sale of Registrable Securities effected pursuant to such registration (less the aggregate
amount of any damages or other amounts such Investor has otherwise been required to pay (pursuant to Section 8(b) or otherwise)
as a result of any untrue statements, alleged untrue statements, omissions or alleged omissions in connection with such registration).

 

(e)               
The indemnification and contribution provided for under this Agreement shall remain in full force and effect regardless
of any investigation made by or on behalf of the indemnified party or any officer, director, manager, agent, representative or
controlling Person of such indemnified party and shall survive the transfer of Registrable Securities and the termination or expiration
of this Agreement.

 

9.                  
Participation in Underwritten Registrations. No Person may participate in any registration hereunder which is underwritten
unless such Person (a) agrees to sell such Person’s securities on the basis provided in any underwriting arrangements approved
by the Person or Persons entitled hereunder to approve such arrangements (including, without limitation, pursuant to any over-allotment
or “green shoe” option requested by the underwriters; provided that no holder of Registrable Securities shall be required
to sell more than the number of Registrable Securities such holder has requested to include) and (b) completes and executes all
questionnaires, powers of attorney, custody agreements, stock powers, indemnities, underwriting agreements and other documents
required under the terms of such underwriting arrangements; provided that no holder of Registrable Securities included in any
underwritten registration shall be required to make any representations or warranties to Pubco or the underwriters (other than
representations and warranties regarding such holder, such holder’s title to the securities, such Person’s authority
to sell such securities and such holder’s intended method of distribution) or to undertake any indemnification obligations
to Pubco or the underwriters with respect thereto that are materially more burdensome than those provided in Section 8.
Each holder of Registrable Securities shall execute and deliver such other agreements as may be reasonably requested by Pubco
and the lead managing underwriter(s) that are consistent with such holder’s obligations under Section 4, Section
5 and this Section 9 or that are necessary to give further effect thereto, and Pubco shall execute and deliver such
other agreements as may be reasonably requested by the lead managing underwriter(s) (if applicable) in order to effect any registration
required hereunder. To the extent that any such agreement is entered into pursuant to, and consistent with, Section 4 and
this Section 9, the respective rights and obligations created under such agreement shall supersede the respective rights
and obligations of the holders, Pubco and the underwriters created pursuant to this Section 9.

 

10.              
Other Agreements.

 

(a)               
For so long as any Investor holds Registrable Securities that may be sold pursuant to Rule 144 only if Pubco is in compliance
with the current public information requirement under Rule 144(c)(1) (or Rule 144(i)(2), if applicable), Pubco will use its commercially
reasonable efforts to make and keep public information available, as those terms are understood and defined in Rule 144 and, in
furtherance thereof, (i) remain subject to the reporting requirements of Section 13 or 15(d) of the Exchange Act; and (ii) timely
(without giving effect to any extensions pursuant to Rule 12b-25 under the Exchange Act, as applicable) file all reports and other
materials required to be filed by Section 13 or 15(d) of the Exchange Act, as applicable (provided, that the failure to file Current
Reports on Form 8-K, other than the Super 8-K (as defined in the Subscription Agreement), shall not be deemed to violate this Section
10(b) to the extent that Rule 144 remains available for the resale of Registrable Securities). Upon reasonable prior written request,
Pubco shall deliver to the Investors a customary written statement as to whether it has complied with such requirements.

 

(b)               
Notwithstanding anything in this Agreement to the contrary, and subject to Section 8(s) of the Subscription Agreements,
in the event that Pubco believes that a notice or communication required by this Agreement to be delivered to any Investor contains
material, nonpublic information relating to Pubco, its securities, any of its affiliates or any other Person, Pubco shall so indicate
to such Investor contemporaneously with delivery of such notice or communication, and such indication shall provide such Investor
the means to refuse to receive such notice or communication; and in the absence of any such indication, the Investors and their
respective affiliates, agents and representatives shall be allowed to presume that all matters relating to such notice or communication
do not constitute material, nonpublic information relating to Pubco, its securities, any of its affiliates or any other Person.
In the event of a breach of any of the foregoing covenants by Pubco, any of its affiliates, or any of its or their respective officers,
directors (or equivalent persons), employees, attorneys, agents or representatives, in addition to any other remedies otherwise
available at law or in equity, each of the Investors shall have the right to make a public disclosure in the form of a press release
or otherwise, of the applicable material nonpublic information without the prior approval by Pubco or any of its affiliates, officers,
directors (or equivalent persons), employees, stockholders, attorneys, agents or representatives, and no Investor (nor any of its
affiliates, agents or representatives) shall have any liability to Pubco, any of its affiliates or any of its or their respective
officers, directors (or equivalent persons), employees, stockholders, attorneys, agents or representatives for any such disclosure.

 

    16

     

    

 

(c)               
 Notwithstanding the foregoing, to the extent Pubco reasonably and in good faith determines that it is necessary to disclose
material non-public information to a Investor in order to comply with its obligations hereunder (a “Necessary Disclosure”),
Pubco shall inform counsel to such Investor (which, with respect to the Deerfield Investors, shall be Katten Muchin Rosenman LLP
(Attn: Mark D. Wood and Jonathan D. Weiner)) of such determination without disclosing the applicable material non-public information,
and Pubco and such counsel on behalf of the applicable Investor shall endeavor to agree upon a process for making such Necessary
Disclosure to the applicable Investor or its representatives that is mutually acceptable to such Investor and Pubco (an “Agreed
Disclosure Process”). Thereafter, Pubco shall be permitted to make such Necessary Disclosure (only) in accordance with
the Agreed Disclosure Process.

 

(d)               
The stock certificates evidencing the Registrable Securities (and/or book entries representing the Registrable Securities)
held by each Investor shall not contain or be subject to any legend restricting the transfer thereof (and the Registrable Securities
shall not be subject to any stop transfer or similar instructions or notations): (A) while a Registration Statement covering the
sale or resale of such securities is effective under the Securities Act, or (B) if such Investor provides customary paperwork to
the effect that it has sold such shares pursuant to Rule 144, or (C) if such Registrable Securities are eligible for sale under
Rule 144(b)(1) as set forth in customary non-affiliate paperwork provided by such Investor, or (D) if at any time on or after the
date that is one year after the Form 10 Disclosure Filing Date such Investor certifies that it is not an affiliate of Pubco and
that such Investor’s holding period for purposes of Rule 144 in respect of such Registrable Securities is at least six (6)
months, or (E) if such legend is not required under applicable requirements of the Securities Act (including judicial interpretations
and pronouncements issued by the staff of the Commission) as determined in good faith by counsel to Pubco or set forth in a legal
opinion delivered by nationally recognized counsel to the Holder (collectively, the "Unrestricted Conditions").
Pubco agrees that following the Registration Date or at such time as any of the Unrestricted Conditions is met or such legend is
otherwise no longer required it will, no later than two (2) Business Days following the delivery by an Investor to Pubco or Pubco’s
transfer agent of a certificate representing any Registrable Securities, issued with a restrictive legend, (or, in the case of
Registrable Securities represented by book entries, delivery by an Investor to Pubco or Pubco’s transfer agent of a legend
removal request) deliver or cause to be delivered to such Investor a certificate or, at the request of such Investor, deliver or
cause to be delivered such Registrable Securities to such Investor by crediting the account of such Investor’s prime broker
with DTC through its Deposit/Withdrawal at Custodian (DWAC) system, in each case, free from all restrictive and other legends and
stop transfer or similar instructions or notations. For purposes hereof, “Registration Date” shall mean the
date that the Resale Shelf Registration Statement covering the Registration Statement has been declared effective by the Commission.
If any of the Unrestricted Conditions is met at the time of issuance of any Registrable Securities (e.g., upon exercise of warrants),
then such securities shall be issued free of all legends. Each Investor shall have the right to pursue any remedies available to
it hereunder, or otherwise at law or in equity, including a decree of specific performance and/or injunctive relief, with respect
to Pubco’s failure to timely deliver shares of Common Stock without legend as required pursuant to the terms hereof.

 

11.              
Definitions.

 

(a)               
“Applicable Approving Party” means the holders of a majority of the Registrable Securities participating
in the applicable offering or, in the case of a Short-Form Registration effected pursuant to Section 2(c), the holders of
a majority of the type of Registrable Securities that initiated such Short-Form Registration.

 

(b)               
“Block Trade” means any non-marketed underwritten takedown offering taking the form of a bought deal
or block sale to a financial institution.

 

    17

     

    

 

(c)               
 “Business Day” means any day that is not a Saturday or Sunday or a legal holiday in the state in which
Pubco’s chief executive office is located or in New York, NY.

 

(d)               
“Capital Stock” means (i) with respect to any Person that is a corporation, any and all shares, interests
or equivalents in capital stock of such corporation (whether voting or nonvoting and whether common or preferred), and (ii) with
respect to any Person that is not a corporation, individual or governmental entity, any and all partnership, membership, limited
liability company or other equity interests of such Person that confer on the holder thereof the right to receive a share of the
profits and losses of, or the distribution of assets of, the issuing Person, including in each case any and all warrants, rights
(including conversion and exchange rights) and options to purchase any of the foregoing.

 

(e)               
“Caremax Group” means each of O.M Investment Group, Inc., C.G.D. Investment Group, Inc., Joseph n. De
Vera, PA, NKP Caremax, LLC and Mouquin Trotter, Inc. and their direct and indirect transferees, if any, who become a party to this
Agreement pursuant to Section 12(f) of this Agreement.

 

(f)                
“Caremax Investors” means the Caremax Group and their direct and indirect transferees, if any, who become
a party to this Agreement pursuant to Section 12(f) of this Agreement.

 

(g)               
“Commission” means the U.S. Securities and Exchange Commission.

 

(h)               
“Common Stock” means the Class A Common Stock of Pubco, par value $0.0001 per share.

 

(i)                
“Deerfield Investors” means the Sponsor, Deerfield Partners, L.P., Steven Hochberg and any Related Deerfield
Fund that becomes a party to this Agreement following the date hereof by execution of a joinder hereto or other written agreement
between such Related Deerfield Fund and Pubco, and any of their respective affiliates and their direct and indirect transferees,
if any, who become a party to this Agreement pursuant to Section 12(f) of this Agreement.

 

(j)                
“Exchange Act” means the Securities Exchange Act of 1934, as amended from time to time, or any successor
federal law then in force, together with all rules and regulations promulgated thereunder.

 

(k)               
“FINRA” means the Financial Industry Regulatory Authority or any successor thereto.

 

(l)                
“Free-Writing Prospectus” means a free-writing prospectus, as defined in Rule 405 of the Securities Act.

 

(m)             
“Form 10 Disclosure Filing Date” means the date on which Pubco shall file with the Commission a Current
Report on Form 8-K that includes current “Form 10 information” (within the meaning of Rule 144) reflecting Pubco’s
status as an entity that is no longer an issuer described in paragraph (i)(1)(i) of Rule 144.

 

(n)               
“IMC Investors” means IMC Holdings, LLC and its direct and indirect transferees, if any, who become a
party to this Agreement pursuant to Section 12(f) of this Agreement.

 

(o)               
“Lock-Up Agreements” means those certain Lock-Up Agreements, dated as of December 18, 2020 by and among
Pubco and certain of the Investors.

 

(p)               
“Majority Caremax Investors” means, as of any date of determination, the holders of a majority of the
Registrable Securities held by the Caremax Investors and their successors and assigns.

 

    18

     

    

 

(q)               
 “Majority Deerfield Investors” means, as of any date of determination, the holders of a majority of
the Registrable Securities held by the Deerfield Investors as of such date; provided, that if any of the shares of Common Stock
held by any of the Deerfield Investors are converted into, or exchanged for, any other securities of Pubco (“Replacement
Securities”) or are convertible into, or exercisable or exchangeable for, Common Stock, then for purposes of this definition,
each holder of such Replacement Securities shall be deemed to hold such Common Stock, and such Common Stock shall be deemed “Registrable
Securities.”

 

(r)                
“Majority IMC Investors” means, as of any date of determination, the holders of a majority of the Registrable
Securities held by the IMC Investors and their successors and assigns.

 

(s)                
“New Registration Statement Filing Deadline” means, with respect to any New Registration Statements that
may be required pursuant to Section 1(b), (i) the tenth (10th) day following the first date on which such Registrable
Securities may then be included in a Registration Statement if such Registration Statement is required to be filed because the
Commission shall have informed Pubco that certain Registrable Securities were not eligible for inclusion in a previously filed
Registration Statement, or (B) if such New Registration Statement is required for a reason other than as described in clause (i)
of this definition, the fifteenth (15th) day following the date on which Pubco first knows that such New Registration
Statement is required.

 

(t)                
“Permitted Transferees” means any Person to whom an Investor is permitted to transfer Registrable Securities
prior to the expiration of the applicable Lock-Up Period (as defined under the applicable Lock-Up Agreement), under the Lock-Up
Agreements, this Agreement or the Business Combination Agreement, and to any permitted transferee thereafter.

 

(u)               
“Person” means an individual, a partnership, a corporation, a limited liability company, an association,
a joint stock company, a trust, a joint venture, an unincorporated organization, any other legal entity or business organization
and a governmental entity or any department, agency or political subdivision thereof.

 

(v)               
“Prospectus” means (i) the prospectus included in any Registration Statement, as supplemented by any
and all prospectus supplements and as amended by any and all post-effective amendments and including all material incorporated
by reference in such prospectus and (ii) any free writing prospectus (within the meaning of Rule 405 under the Securities Act)
relating to any offering of Registrable Securities pursuant to a Registration Statement.

 

(w)             
“Public Offering” means any sale or distribution by Pubco and/or holders of Registrable Securities to
the public of Common Stock pursuant to an offering registered under the Securities Act.

 

(x)               
“Register,” “Registered” and “Registration” mean a registration
effected by preparing and filing a Registration Statement or similar document in compliance with the requirements of the Securities
Act, and the applicable rules and regulations promulgated thereunder, and such Registration Statement becoming effective.

 

    19

     

    

 

(y)                “Registrable
Securities” means (i) any Founder Shares held by the Investors, (ii) any shares of Common Stock issued to an
Investor, or issuable upon exercise of warrants issued to an Investor, in Pubco’s initial public offering, (iii) any
Private Placement Warrants (or underlying securities) held by the Investors, (iv) any PIPE Shares held or later acquired by
the Investors, (v) any shares of Common Stock issued to an Investor pursuant to the terms of the Business Combination
Agreement, (vi) any other shares of Common Stock or warrants to purchase shares of Common Stock held or later acquired by an
Investor, (vii) any shares of Common Stock issued or issuable upon the exercise, conversion or exchange of, or pursuant to
anti-dilution provisions applicable to, securities hereafter issued in exchange or substitution for, or otherwise with
respect to, securities referred to in clauses (i) through (vi) by way of reclassification, exchange or otherwise, and (vii)
any Common Stock issued or issuable with respect to the securities referred to in the preceding clauses (i) through (vii) by
way of a stock dividend or stock split or in connection with a combination of shares, recapitalization, merger, consolidation
or other reorganization. As to any particular Registrable Securities, such securities shall cease to be Registrable
Securities when they have been sold or distributed to the public pursuant to an offering registered under the Securities Act
or sold to the public through a broker, dealer or market maker in compliance with Rule 144 following the consummation of the
Business Combination or repurchased by Pubco or any of its subsidiaries. For purposes of this Agreement, a Person shall be
deemed to be a holder of Registrable Securities, and the Registrable Securities shall be deemed to be in existence, whenever
such Person holds such Registrable Securities of record or in “street name” or has the right to acquire directly
or indirectly such Registrable Securities (upon conversion or exercise in connection with a transfer of securities or
otherwise, but disregarding any restrictions or limitations upon the exercise of such right and, in the case of Registrable
Securities issuable upon exercise of warrants, assuming the exercise thereof for cash), whether or not such acquisition has
actually been effected, and such Person shall be entitled to exercise the rights of a holder of Registrable Securities
hereunder; provided a holder of Registrable Securities may only request that Registrable Securities in the form of Common
Stock be registered pursuant to this Agreement.

 

(z)               
“Registration Statement” means any registration statement filed by Pubco with the Commission in compliance
with the Securities Act and the rules and regulations promulgated thereunder for a public offering and sale of Common Stock or
Registrable Securities, including the Prospectus included in such registration statement, amendments (including post-effective
amendments) and supplements to such registration statement, and all exhibits to and all material incorporated by reference in such
registration statement.

 

(a)              
“Related Deerfield Fund” means any investment fund or managed account that is managed on a discretionary
basis by the same investment manager as Deerfield Partners, L.P.

 

(aa)            
“Rule 144”, “Rule 405” and “Rule 415” mean, in each case, such
rule promulgated under the Securities Act (or any successor provision) by the Commission, as the same shall be amended from time
to time, or any successor rule then in force.

 

(bb)           
“Securities Act” means the Securities Act of 1933, as amended from time to time, or any successor federal
law then in force, together with all rules and regulations promulgated thereunder.

 

(cc)            
“Shelf Participant” means any holder of Registrable Securities listed as a potential selling stockholder
in connection with the Resale Shelf Registration Statement or the Shelf Registration or any such holder that could be added to
such Resale Shelf Registration Statement or Shelf Registration without the need for a post-effective amendment thereto or added
by means of an automatic post-effective amendment thereto.

 

(dd)           
“WKSI” means a “well-known seasoned issuer” as defined under Rule 405.

 

12.              
Miscellaneous.

 

(a)               
No Inconsistent Agreements. Pubco shall not hereafter enter into any agreement with respect to its securities which
is inconsistent with or violates or in any way impairs the rights granted to the Investors in this Agreement.

 

(b)               
Entire Agreement. This Agreement constitutes the entire agreement of the parties hereto with respect to the subject
matter hereof and supersedes all prior agreements, understandings, negotiations and discussions among the parties hereto, written
or oral, with respect to the subject matter hereof, and amends and restates the Prior Agreement its entirety.

 

    20

     

    

 

(c)               
 Remedies. Any Person having rights under any provision of this Agreement shall be entitled to enforce such rights
specifically (without posting a bond or other security), to recover damages caused by reason of any breach of any provision of
this Agreement and to exercise all other rights granted by law. The parties hereto agree and acknowledge that money damages would
not be an adequate remedy for any breach of the provisions of this Agreement and that, in addition to any other rights and remedies
existing in its favor, any party shall be entitled to specific performance and/or other injunctive relief from any court of law
or equity of competent jurisdiction (without posting any bond or other security) in order to enforce or prevent violation of the
provisions of this Agreement.

 

(d)               
Amendments and Waivers. Except as otherwise provided herein, the provisions of this Agreement may be amended or waived
only with the prior written consent of Pubco and the holders of a majority of the Registrable Securities then outstanding; provided,
that (i) such majority shall include the Majority Deerfield Investors for so long as the Majority Deerfield Investors hold at least
5% of the outstanding Common Stock on the date of such amendment or waiver, provided that for so long as the Deerfield Investors
hold any Registrable Securities, such majority shall include the Majority Deerfield Investors in all cases to amend or waive any
provision of Section 1, Section 2(f), Section 4(a), Section 10 and this Section 12(d) hereof
and any related definitions (including the definition of “Deerfield Investors” and “Majority Deerfield Investors”),
(ii) such majority shall include the Majority IMC Investors for so long as the Majority IMC Investors hold at least 5% of the outstanding
Common Stock on the date of such amendment or waiver and (iii) such majority shall include the Majority Caremax Investors for so
long as the Majority Caremax Investors hold at least 5% of the outstanding Common Stock on the date of such amendment or waiver,
provided, further, that no amendment may materially and disproportionately adversely affect the rights of any holder of Registrable
Securities compared to other holders of Registrable Securities without the consent of such adversely affected holder. Any amendment
or waiver effected in accordance with this Section 12(d) shall be binding upon each Investor and Pubco. The failure of any
party to enforce any of the provisions of this Agreement shall in no way be construed as a waiver of such provisions and shall
not affect the right of such party thereafter to enforce each and every provision of this Agreement in accordance with its terms.

 

(e)               
Successors and Assigns. All covenants and agreements in this Agreement by or on behalf of any of the parties hereto
shall bind and inure to the benefit of the respective successors and permitted assigns of the parties hereto whether so expressed
or not. In addition, whether or not any express assignment has been made, the provisions of this Agreement which are for the benefit
of purchasers or holders of Registrable Securities are also for the benefit of, and enforceable by, any subsequent holder of Registrable
Securities and any subsequent holder of securities that are convertible into, or exercisable or exchangeable for, Registrable Securities.
Pubco shall not assign its obligations hereunder without the prior written consent of the holders of a majority of the Registrable
Securities then outstanding; provided, that such majority shall include the Majority Deerfield Investors for so long as the Majority
Deerfield Investors hold at least 5% of the outstanding Common Stock on the date such consent is sought.

 

(f)                 Transfer
of Rights. An Investor may transfer or assign, in whole or from time to time in part, to one or more Permitted
Transferees, its rights and obligations under this Agreement and such rights will be transferred to such transferee effective
upon receipt by Pubco of (A) written notice from such Investor stating the name and address of the transferee and identifying
the number of Registrable Securities with respect to which rights under this Agreement are being transferred and the nature
of the rights so transferred), and (B) except in the case of a transfer to an existing Investor, a written agreement from
such transferee to be bound by the terms of this Agreement. A transferee of Registrable Securities who satisfies the
conditions set forth in this Section 12(f) shall henceforth be an “Investor” for purposes of this
Agreement and in the case of a transfer from a Caremax Investor, IMC Investor or Deerfield Investor, a transferee shall be
considered a Caremax Investor, IMC Investor or Deerfield Investor as shall be applicable. In the event a holder transfers
Registrable Securities included on a Registration Statement and such Registrable Securities remain Registrable Securities
following such transfer, at the request of such holder, Pubco shall use its reasonable best efforts to amend or supplement
the Resale Shelf Registration Statement as may be necessary in order to enable such transferee to offer and sell such
Registrable Securities pursuant to such Resale Shelf Registration Statement; provided that in no event shall Pubco be
required to file a post-effective amendment to the Resale Shelf Registration Statement unless Pubco receives a written
request from the subsequent transferee, requesting that its shares of Common Stock be included in the Resale Shelf
Registration Statement, with all information reasonably requested by Pubco.

 

    21

     

    

 

 

(g)               
Severability. Whenever possible, each provision of this Agreement shall be interpreted in such manner as to be effective
and valid under applicable law, but if any provision of this Agreement is held to be prohibited by or invalid, illegal or unenforceable
in any respect under any applicable law, such provision shall be ineffective only to the extent of such prohibition, invalidity,
illegality or unenforceability, without invalidating the remainder of this Agreement.

 

(h)               
Counterparts. This Agreement may be executed simultaneously in counterparts (including by means of facsimile, electronic
mail, portable data format (PDF) or other electronic signature pages), any one of which need not contain the signatures of more
than one party, but all such counterparts taken together shall constitute one and the same Agreement.

 

(i)                
Descriptive Headings; Interpretation. The descriptive headings of this Agreement are inserted for convenience only
and do not constitute a part of this Agreement. Unless the context otherwise required: (i) the use of the word “including”
herein shall mean “including without limitation,” (ii) all references to Sections, Schedules or Exhibits are to Sections,
Schedules or Exhibits contained in or attached to this Agreement, and (iii) words in the singular or plural include the singular
and plural, and pronouns stated in either the masculine, the feminine or neuter gender shall include the masculine, feminine and
neuter.

 

(j)                
Governing Law; Jurisdiction. All issues and questions concerning the construction, validity, enforcement and interpretation
of this Agreement and the exhibits and schedules hereto shall be governed by, and construed in accordance with, the laws of the
State of Delaware, without giving effect to any choice of law or conflict of law rules or provisions (whether of the State of Delaware
or any other jurisdiction) that would cause the application of the laws of any jurisdiction other than the State of Delaware. The
parties hereto agree that any suit, action or proceeding seeking to enforce any provision of, or based on any matter arising out
of or in connection with, this Agreement or the transactions contemplated hereby shall be brought in any Delaware Chancery Court,
or if such court does not have subject matter jurisdiction, any court of the United States located in the State of Delaware. Each
of the parties hereby irrevocably consents to the jurisdiction of such courts (and of the appropriate appellate courts therefrom)
in any such suit, action or proceeding and irrevocably waives, to the fullest extent permitted by law, any objection that it may
now or hereafter have to the laying of the venue of any such suit, action or proceeding in any such court or that any such suit,
action or proceeding brought in any such court has been brought in an inconvenient forum. Process in any such suit, action or proceeding
may be served on any party anywhere in the world, whether within or without the jurisdiction of any such court.

 

(k)               
Notices. All notices, demands or other communications to be given or delivered under or by reason of the provisions
of this Agreement shall be in writing and shall be given (and shall be deemed to have been duly given upon receipt) by delivery
in person, by or email or by registered or certified mail (postage prepaid, return receipt requested) to each Investor at the address
indicated on the Schedule of Investors attached hereto and to Pubco at the address indicated below (or at such other address as
shall be specified in a notice given in accordance with this Section 12(k)):

 

Deerfield Healthcare
Technology Acquisitions Corp.

780 Third Avenue

New York, New York 10017

Email: chris.wolfe@dfbhealthcare.com

Attention: Chris Wolfe

 

    23

     

    

 

with a copy to:

 

White & Case LLP

1221 Avenue of the Americas

New York, New York 10020

Email:           joel.rubinstein@whitecase.com

                     bryan.luchs@whitecase.com

Attention:     Joel Rubinstein

                     Bryan J. Luchs

 

(l)                
Mutual Waiver of Jury Trial. As a specifically bargained inducement for each of the parties to enter into this Agreement
(with each party having had opportunity to consult counsel), each party hereto expressly and irrevocably waives the right to trial
by jury in any lawsuit or legal proceeding relating to or arising in any way from this Agreement or the transactions contemplated
herein, and any lawsuit or legal proceeding relating to or arising in any way to this Agreement or the transactions contemplated
herein shall be tried in a court of competent jurisdiction by a judge sitting without a jury.

 

(m)             
No Strict Construction. The parties hereto have participated jointly in the negotiation and drafting of this Agreement.
In the event an ambiguity or question of intent or interpretation arises, this Agreement shall be construed as if drafted jointly
by the parties hereto, and no presumption or burden of proof shall arise favoring or disfavoring any party by virtue of the authorship
of any of the provisions of this Agreement.

 

* * * * *

 

    24

     

    

 

IN WITNESS WHEREOF,
the parties hereto have executed this Amended and Restated Registration Rights Agreement as of the date first written above.

 

	 	DEERFIELD HEALTHCARE TECHNOLOGY ACQUISITIONS CORP.
	 	 	 
	 	By:	 /s/ Christopher Wolfe 
	 	 	Name: Christopher Wolfe
	 	 	Title: Chief Financial Officer

 

	 	INVESTORS:
	 	 
	 	DFHTA SPONSOR LLC
	 	 	 
	 	By:	 /s/ Lawrence Atinsky
	 	 	Name: Lawrence Atinsky
	 	 	Title: Manager

 

	 	DEERFIELD
    PARTNERS, L.P.
	 	 
	 	By:	Deerfield
    Mgmt, L.P.
	 	 	General
    Partner
	 	 
	 	By:	J.E.
    Flynn Capital, LLC
	 	 	General
    Partner

 

	 	By:	 /s/ David J. Clark
	 	 	Name: David J. Clark
	 	 	Title: Authorized Signatory

 

	 	IMC HOLDINGS, LLC
	 	 	 
	 	By:	 /s/ William C. Lamoreaux
	 	 	Name: William C. Lamoreaux
	 	 	Title: Chief Executive Officer

 

	 	O.M. INVESTMENT GROUP, INC.
	 	 	 
	 	By:	 /s/ Carlos A. de Solo
	 	 	Name: Carlos A. de Solo
	 	 	Title: Chief Executive Officer

 

    

     

    

 

	 	C.G.D. INVESTMENT GROUP, INC.
	 	 	 
	 	By:	 /s/ Alberto R. de Solo
	 	 	Name: Alberto R. de Solo
	 	 	Title: Chief Executive Officer

 

	 	JOSEPH N. DE VERA, PA
	 	 	 
	 	By:	 /s/ Joseph N. De Vera
	 	 	Name: Joseph N. De Vera
	 	 	Title: Chief Executive Officer

 

	 	NKP CAREMAX, LLC
	 	 	 
	 	By:	 /s/ Nayan K. Pathak
	 	 	Name: Nayan K. Pathak
	 	 	Title: Manager 

 

	 	MOUQUIN TROTTER, INC.
	 	 	 
	 	By:	 /s/ Benjamin Quirk
	 	 	Name: Benjamin Quirk
	 	 	Title: President 

 

	 	 /s/ Richard Barasch
	 	Richard Barasch

 

	 	 /s/ Steven Hochberg
	 	Steven Hochberg

 

	 	 /s/ Christopher Wolfe
	 	Christopher Wolfe

 

	 	 /s/ Dr. Peter J. Fitzgerald
	 	Dr. Peter J. Fitzgerald

 

	 	 /s/ Dr. Linda Grais
	 	Dr. Linda Grais

 

	 	 /s/ Hon. Dr. David J. Shulkin
	 	Hon. Dr. David J. Shulkin

 

    2

     

    

 

SCHEDULE OF INVESTORS

 

	Investor	Address 
	DFHTA Sponsor LLC	
        DFHTA Sponsor LLC

        780 Third Avenue, 37th Floor

        New York, NY 10017

        E-mail:
        latinsky@deerfield.com

        Attn: Lawrence Atinsky

         

        With a copy
        (which shall not be deemed to constitute notice) to:

         

        Katten Muchin Rosenman LLP

        525 West Monroe Street

        Chicago, IL 60661

        Facsimile No.: (312) 902-5493

        Telephone No.: (312) 902-1061

        Attn: Mark D. Wood

        Email: mark.wood@katten.com

	Deerfield
                                         Partners, L.P.
 Steven Hochberg
 

                                                                                 
	
        Deerfield Partners, L.P.

        780 Third Avenue, 37th Floor

        New York, NY 10017

        E-mail: dclark@deerfield.com

        Attn: David
        J. Clark

         

        With a copy
        (which shall not be deemed to constitute notice) to:

         

        Katten Muchin Rosenman LLP

        525 West Monroe Street

        Chicago, IL 60661

        Facsimile No.: (312) 902-5493

        Telephone No.: (312) 902-1061

        Attn: Mark D. Wood

        Email:
mark.wood@katten.com 

         

	IMC Holdings, LLC	
        IMC Holdings, LLC

        c/o Comvest Investment Partners Holdings, LLC

        525 Okeechobee Boulevard, Suite 1010

        West Palm Beach, Florida 33401

        Email: r.marrero@comvest.com and m.griffin@comvest.com

        Attention: Roger Marrero and Marshal Griffin

         

        With a copy
        (which shall not be deemed to constitute notice) to:

         

        McDermott Will & Emery LLP

        333 Avenue of the Americas, Suite 4500

        Miami, Florida 33131

        Email: flevenson@mwe.com and ibarakat@mwe.com

        Attention: Fred Levenson and Ibrahim Barakat

         

	O.M. Investment Group, Inc.	
        O.M. Investment
        Group, Inc.

        8700 West
        Flagler Street

        Ste. 400

        Miami, FL
        33174

        Attn: Carlos
        A. de Solo

        Email: carlos@caremax.net

 

    

     

    

 

	C.G.D. Investment Group, Inc.	
        C.G.D. Investment
        Group, Inc.

        8700 West
        Flagler Street

        Ste. 400

        Miami, FL
        33174

        Attn: Alberto
        R. de Solo

        Email: ardesolo@caremax.net

	Joseph N. De Vera, Inc.	
        Joseph N.
        De Vera, Inc.

        8700 West
        Flagler Street

        Ste. 400

        Miami, FL
        33174

        Attn: Joseph
        N. De Vera, Inc.

        Email: jdevera@caremax.net

	NKP Caremax, LLC	
        NKP Caremax,
        LLC

        8423 SW
        137th Street

        Palmetto
        Bay, FL 33158

        Attn: Nayan
        K. Pathak

        Email: nayan.pathak@nkpcapital.com

	Mouquin Trotter, Inc.	
        Mouquin
        Trotter, Inc.

        8700 West
        Flagler Street

        Ste. 400

        Miami, FL
        33174

        Attn: Benjamin
        Quirk

        Email: ben.quirk@careoptimize.com

	Richard Barasch

Christopher Wolfe

Dr. Peter J. Fitzgerald

Dr. Linda Grais

Hon. Dr. David J. Shulkin	
        c/o Deerfield Healthcare Technology Acquisitions Corp.

        780 Third Avenue, 37th Floor

        New York, NY 10017

        E-mail:
        chris.wole@dfbhealthcare.com

        Attn: Chris Wolfe

         

 

    2

     

    

 

AMENDED AND RESTATED REGISTRATION RIGHTS
AGREEMENT JOINDER

 

The undersigned is
executing and delivering this Joinder pursuant to the Amended and Restated Registration Rights Agreement dated as of _______________
(as the same may hereafter be amended, the “Registration Rights Agreement”), among Deerfield Healthcare Technology
Acquisitions Corp., a Delaware corporation (“Pubco”), and the other persons named as parties therein.

 

By executing and delivering
this Joinder to Pubco, the undersigned hereby agrees to become a party to, to be bound by, and to comply with the provisions of
the Registration Rights Agreement as a holder of Registrable Securities in the same manner as if the undersigned were an original
signatory to the Registration Rights Agreement.

 

Accordingly, the undersigned
has executed and delivered this Joinder as of the ___ day of ________, 20__.

 

	 	INVESTOR:
	 	 
	 	[●]
	 	 
	                                 	By: 	                       
	 	 
	 	Its:
	 	 
	 	Address
    for Notices: [●]
	 	  
	 	[●]
	 	 
	 	[●]
	 	 
	 	[●]
	 	 
	 	Agreed
    and Accepted as of _________________
	 	 
	 	DEERFIELD
    HEALTHCARE TECHNOLOGY ACQUISITIONS CORP.
	 	 
	 	By:	 
	 	 
	 	Its:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00318-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00318-of-00352.parquet"}]]